ULTRATECH INC - FORM 10-Q - November 3, 2010

ULTRATECH INC - FORM 10-Q - November 3, 2010

Attached files

Attached files

ULTRATECH INC Reports

Also read

file	filename
EX-32.1 - CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - ULTRATECH INC	dex321.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER REQUIRED PURSUANT TO SECTION 302 - ULTRATECH INC	dex311.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER REQUIRED PURSUANT TO SECTION 302 - ULTRATECH INC	dex312.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

þ	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended October 2, 2010

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 0-22248

ULTRATECH, INC.

(Exact name of registrant as specified in its charter)


DELAWARE		94-3169580
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

3050 Zanker Road, San Jose, California		95134
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code (408) 321-8835

(Former name, former address and former fiscal year, if changed since last report.)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No þ

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:


Class		Outstanding as of October 29, 2010
common stock, $0.01 par value		24,421,888

ULTRATECH, INC.

INDEX


PART I. FINANCIAL INFORMATION
Item 1. Financial Statements			3
Condensed Consolidated Balance Sheets as of October 2, 2010 and December 31, 2009			3
Condensed Consolidated Statements of Operations for the three and nine months ended October 2, 2010 and October 3, 2009			4
Condensed Consolidated Statements of Cash Flows for the nine months ended October 2, 2010 and October 3, 2009			5
Notes to Condensed Consolidated Financial Statements			6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			19
Item 3. Quantitative and Qualitative Disclosures About Market Risk			25
Item 4. Controls and Procedures			26
PART II. OTHER INFORMATION
Item 1. Legal Proceedings			27
Item 1A. Risk Factors			27
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds			35
Item 3. Defaults Upon Senior Securities			35
Item 4. Reserved			35
Item 5. Other Information			35
Item 6. Exhibits			36
SIGNATURES			37
EXHIBIT 31.1
EXHIBIT 31.2
EXHIBIT 32.1

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements

ULTRATECH, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS


(In thousands)	October 2, 2010		December 31, 2009*
	(Unaudited)
*ASSETS*
Current assets:
Cash and cash equivalents	$	58,749	$	58,617
Short-term investments		125,924		101,724
Accounts receivable, net		30,312		31,426
Inventories		33,956		25,881
Prepaid expenses and other current assets		6,684		4,163

Total current assets		255,625		221,811
Equipment and leasehold improvements, net		12,151		9,841
Other assets		3,392		2,929

Total assets	$	271,168	$	234,581

*LIABILITIES AND STOCKHOLDERS’ EQUITY*
Current liabilities:
Notes payable	$	6,000	$	6,000
Accounts payable		15,097		7,112
Deferred product and services income		15,953		8,846
Other current liabilities		11,799		6,720

Total current liabilities		48,849		28,678
Other liabilities		4,275		5,935
Stockholders’ equity		218,044		199,968

Total liabilities and stockholders’ equity	$	271,168	$	234,581

*	The Balance Sheet as of December 31, 2009 has been derived from the audited financial statements at that date.

See accompanying notes to unaudited condensed consolidated financial statements

ULTRATECH, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


	Three Months Ended						Nine Months Ended
(In thousands, except per share amounts)	October 2, 2010			October 3, 2009			October 2, 2010			October 3, 2009
Net sales:
Products	$	33,814		$	21,050		$	85,419		$	58,177
Services		3,998			3,889			11,322			10,931
Licenses		125			—			250			82

Total net sales		37,937			24,939			96,991			69,190
Cost of sales:
Cost of products sold		16,274			9,436			39,008			28,351
Cost of services		3,141			2,939			8,754			8,751

Total cost of sales		19,415			12,375			47,762			37,102

Gross profit		18,522			12,564			49,229			32,088
Operating expenses:
Research, development, and engineering		4,980			4,573			14,610			14,208
Selling, general, and administrative		8,634			7,262			24,091			20,186

Operating income (loss)		4,908			729			10,528			(2,306	)
Interest income (expense)		(6	)		(16	)		(1	)		293
Interest and other income, net		92			327			288			2,721

Income before income tax		4,994			1,040			10,815			708
Provision (benefit) for income taxes		92			(1	)		348			(37	)

Net income	$	4,902		$	1,041		$	10,467		$	745

Net income per share - basic	$	0.20		$	0.04		$	0.43		$	0.03
Number of shares used in per share computations - basic		24,370			23,707			24,204			23,664
Net income per share - diluted	$	0.20		$	0.04		$	0.42		$	0.03
Number of shares used in per share computations - diluted		25,067			23,805			24,692			23,745

See accompanying notes to unaudited condensed consolidated financial statements

ULTRATECH, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


	Nine Months Ended
(In thousands)	October 2, 2010			October 3, 2009
Cash flows from operating activities:
Net income	$	10,467		$	745
Adjustments to reconcile net income to net cash provided (used) by operating activities:
Depreciation		2,319			3,325
Amortization		208			359
Accretion of asset retirement obligations		73			115
Loss on disposal of equipment		112			119
Stock-based compensation		3,202			1,832
Deferred income taxes		27			(12	)
Changes in operating assets and liabilities:
Accounts receivable		1,114			(7,481	)
Inventories		(8,075	)		2,042
Prepaid expenses and other current assets		(2,506	)		837
Other assets		(577	)		141
Accounts payable		7,985			(2,622	)
Deferred product and services income		7,107			(1,841	)
Other current liabilities		5,079			(4,521	)
Other liabilities		(1,760	)		(388	)

Net cash provided (used) by operating activities		24,775			(7,350	)

Cash flows from investing activities:
Capital expenditures		(4,677	)		(3,012	)
Proceeds from sales of fixed assets		—			10
Purchase of investments in securities		(122,343	)		(60,164	)
Proceeds from maturities of investments		97,972			53,126

Net cash used in investing activities		(29,048	)		(10,040	)

Cash flows from financing activities:
Proceeds from notes payable		18,000			28,055
Repayment of notes payable		(18,000	)		(24,105	)
Proceeds from issuance of common stock for stock option exercises		4,453			408
Tax payment for issuance of common stock from release of restricted stock units		(48	)		(454	)

Net cash provided by financing activities		4,405			3,904

Net increase (decrease) in cash and cash equivalents		132			(13,486	)
Cash and cash equivalents at beginning of period		58,617			94,034

Cash and cash equivalents at end of period	$	58,749		$	80,548

Supplemental disclosures of cash flow information:
Other non-cash activities:
Systems transferred from inventory to equipment and other assets	$	—		$	273

See accompanying notes to unaudited condensed consolidated financial statements

Ultratech, Inc.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

October 2, 2010

(1) Description of Business

Ultratech, Inc. (referred to herein as “Ultratech,” the “Company”, “we”, “our” or “us”) develops, manufactures and markets photolithography and laser thermal processing equipment designed to reduce the cost of ownership for manufacturers of integrated circuits and nanotechnology components located throughout North America, Europe, Japan, Taiwan and the rest of Asia.

We supply step-and-repeat photolithography systems based on one-to-one imaging technology. Within the integrated circuits industry, we target the market for advanced packaging applications. Within the nanotechnology industry, our target markets include thin film head magnetic recording devices, ink jet print heads, laser diodes and high-brightness light emitting diodes (“HBLEDs”). Our laser thermal processing equipment is targeted at advanced annealing applications within the semiconductor industry.

In evaluating our business, we gave consideration to the Chief Executive Officer’s review of financial information and the organizational structure of our management. Based on this review, we concluded that, at the present time, resources are allocated and other financial decisions are made based on our consolidated financial information. Accordingly, we have determined that we operate in one business segment, which is the manufacture and distribution of capital equipment to manufacturers of integrated circuits and nanotechnology components.

(2) Basis of Presentation

The accompanying condensed consolidated financial statements include our accounts and the accounts of our subsidiaries. All intercompany accounts and transactions have been eliminated.

Our interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) for interim financial information and the rules and regulations of the Securities and Exchange Commission (SEC) for interim financial statements and accounting policies, consistent, in all material respects with those applied in preparing our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2009, filed with the SEC on March 1, 2010 (2009 Form 10-K) and include all adjustments, consisting of only normal recurring adjustments considered necessary for fair presentation.

Our fiscal periods end on the Saturday closest to month-end, except that our fiscal year ends on December 31. All references to the quarter refer to our fiscal quarter. Our fiscal quarters covered by this report ended on October 2, 2010 and October 3, 2009, respectively.

Operating results for the three and nine months ended October 2, 2010 are not necessarily indicative of the results that may be expected for the year ending December 31, 2010 or any future periods.

Certain immaterial amounts of service and product costs for prior periods have been reclassified between product cost of sales and service cost of sales in the Condensed Consolidated Statements of Operations to be consistent with current presentation.

USE OF ESTIMATES — The preparation of the consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and the related disclosure of contingent assets and liabilities at the date of the consolidated financial statements. By their nature, these estimates and judgments are subject to an inherent degree of uncertainty. On an ongoing basis, we evaluate our estimates, including those related to inventories, warranty obligations, purchase order commitments, asset retirement obligations, bad debts, estimated useful lives of fixed assets, asset impairment, income taxes, intangible assets, contingencies and litigation. We base our estimates on historical experience and on various other analyses and assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS — In September 2009, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2009-13, Revenue Recognition (Topic 605) – Multi-Deliverables Revenue Arrangements, a Consensus of the FASB Emerging Issues Task Force, to address the accounting

Ultratech, Inc.

Notes to Condensed Consolidated Financial Statements—(Continued)

(Unaudited)

October 2, 2010

for multiple-deliverable arrangements to enable vendors to account for products or services (deliverables) separately rather than as a combined unit. It establishes the accounting and reporting guidance for arrangements under which the vendor will perform multiple revenue-generating activities, specifically, how to separate deliverables and how to measure and allocate arrangement consideration to one or more units of accounting. The update will be effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on January 1, 2011. We are currently evaluating the impact, if any, of adopting the update.

In October 2009, the FASB issued ASU No. 2009-14, Software (Topic 985) – Certain Revenue Arrangements That Include Software Element, a Consensus of the FASB Emerging Issues Task Force, to address concerns relating to the accounting for revenue arrangements that contain tangible products and software. It requires a vendor to use vendor-specific objective evidence of selling price to separate deliverables in a multiple-element arrangement. The update will be effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on January 1, 2011. We are currently evaluating the impact, if any, of adopting the update.

In January 2010, the FASB issued ASU No. 2010-06, Fair Value Measurements and Disclosures (Topic 820) – Improving Disclosures about Fair Value Measurements, to provide amendments to Subtopic 820-10 that require new disclosures for transfers in and out of Levels 1 and 2 and for activity in Level 3 fair value measurements. It also clarifies existing disclosures for level of disaggregation and disclosures about inputs and valuation techniques. The update is effective for interim and annual reporting periods beginning on January 1, 2010, except for the disclosures of roll forward activities in Level 3 fair value measurements. Those disclosures are effective for interim and annual reporting periods beginning on January 1, 2011. The adoption of the update did not have an impact on our results of operations or financial position.

(3) Stock-Based Compensation

Stock-based compensation expense recognized under ASC Topic 718, Compensation – Stock Compensation (“ASC 718”), for employees and directors and the effect on our Condensed Consolidated Statements of Operations were as follows:


	Three Months Ended				Nine Months Ended
(In thousands)	October 2, 2010		October 3, 2009		October 2, 2010		October 3, 2009
Cost of sales	$	90	$	39	$	220	$	97
Research, development, and engineering		255		139		595		349
Selling, general and administrative expenses		1,005		560		2,387		1,387

Total stock-based compensation expense	$	1,350	$	738	$	3,202	$	1,833

Compensation cost capitalized as part of inventory was immaterial during each of the three month and nine month periods ended October 2, 2010 and October 3, 2009, respectively.

As required by ASC 718, we estimate expected forfeitures and recognize compensation costs only for those equity awards expected to vest. As of October 2, 2010, there were $11.4 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under our 1993 Stock Option Plan/Stock Issuance Plan, as amended (“1993 Plan”), and our 1998 Supplemental Stock Option/Stock Issuance Plan, as amended ( “1998 Plan”). The costs related to stock options and restricted stock units are expected to be recognized over a weighted average period of 5.4 years and 2.6 years, respectively.

These plans provide for the grant of stock-based awards to our eligible employees, consultants and advisors and non-employee directors. We believe that such awards better align the interests of our employees with those of our stockholders. There were no shares reserved for future awards under the 1998 Plan since the plan expired on October 19, 2008. However, as of October 2, 2010, there were 1.7 million shares reserved for future awards under the 1993 Plan.

Ultratech, Inc.

Notes to Condensed Consolidated Financial Statements—(Continued)

(Unaudited)

October 2, 2010

We used the following weighted-average assumptions to estimate the fair value of our stock options granted during the three month and nine month periods ended October 2, 2010 and October 3, 2009, respectively:


	Three Months Ended				Nine Months Ended
	October 2,			October 3,	October 2,			October 3,
	2010			2009	2010			2009
Expected life (in years)		8.2		*		8.1			5.2
Risk-free interest rate		2.8	%	*		3.2	%		1.8	%
Volatility		51	%	*		51	%		51	%
Dividend yield		—		*		—			—

*	No stock options were granted for this period.

A majority of our stock options granted during the three month period ended October 2, 2010 were granted with a vesting term of 100 months and the remaining were granted with a vesting term of 50 months. As such, the weighted-average expected life of our stock options granted during the three months ended October 2, 2010 increased to 8.2 years.

(4) Basic and Diluted Net Income (Loss) Per Share

The following table sets forth the computation of basic and diluted net income per share:


	Three Months Ended				Nine Months Ended
	October 2,		October 3,		October 2,		October 3,
(In thousands, except per share amounts)	2010		2009		2010		2009
Numerator:
Net income	$	4,902	$	1,041	$	10,467	$	745
Denominator:
Basic weighted-average shares outstanding		24,370		23,707		24,204		23,664
Effect of dilutive employee stock options and restricted stock units		697		98		488		81

Diluted weighted-average shares outstanding		25,067		23,805		24,692		23,745

Net income per share - basic:
Net income	$	0.20	$	0.04	$	0.43	$	0.03

Net income per share - diluted:
Net income	$	0.20	$	0.04	$	0.42	$	0.03

For the three month and nine month periods ended October 2, 2010, 1.3 million weighted average shares and 1.5 million weighted average shares of common stock subject to outstanding options were excluded in the computation of diluted net income per share, respectively, as the effect would have been anti-dilutive, as compared to 3.8 million and 4.0 million shares of common stock subject to outstanding options in the corresponding periods of 2009, respectively. In addition, for each of the three month and nine month periods ended October 2, 2010 and October 3, 2009, respectively, the number of shares of common stock underlying outstanding restricted stock units excluded from the computation was immaterial. Options and restricted stock units are anti-dilutive when we have a net loss or when the exercise price and the average unrecognized compensation cost of the stock option or restricted stock unit is greater than the average market price of our common stock during the period.

(5) Fair Value Measurements

Fair value is defined under ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”) as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value which are the following:

•

Level 1 - Quoted prices for identical assets or liabilities in active markets.

•

Level 2 - Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.

•

Level 3 - Model derived valuations in which one or more significant inputs or significant value drivers are unobservable.

Ultratech, Inc.

Notes to Condensed Consolidated Financial Statements—(Continued)

(Unaudited)

October 2, 2010

We measure certain financial assets and liabilities at fair value on a recurring basis, including available-for-sale securities and foreign currency derivatives. The fair value of these certain financial assets and liabilities was determined using the following inputs at October 2, 2010 and December 31, 2009, respectively:


	Fair Value Measurements at October 2, 2010 Using
(In thousands)	Total			Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Available-for-sale securities⁽¹⁾
Commercial papers	$	13,347		$	—	$	13,347	$	—
Money market funds		9,175			9,175		—		—
U.S. corporate debt securities		—			—		—		—
U.S. treasury bills and notes		—			—		—		—
Securities and obligations of U.S. government agencies		121,925			—		121,925		—

		144,447			9,175		135,272		—
Foreign currency derivatives⁽²⁾		5			—		5		—
Deferred compensation plan assets⁽³⁾		899			—		—		899
Deferred compensation plan liabilities⁽⁴⁾		(1,136	)		—		—		(1,136	)

	$	144,215		$	9,175	$	135,277	$	(237	)


	Fair Value Measurements at December 31, 2009 Using
(In thousands)	Total			Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Available-for-sale securities⁽¹⁾
Commercial papers	$	13,996		$	—	$	13,996	$	—
Money market funds		15,739			15,739		—		—
U.S. corporate debt securities		1,193			—		1,193		—
U.S. treasury bills and notes		15,200					15,200		—
Securities and obligations of U.S. government agencies		83,338			—		83,338		—

		129,465			15,739		113,726		—
Foreign currency derivatives⁽²⁾		79			—		79		—
Deferred compensation plan assets⁽³⁾		1,032			—		—		1,032
Deferred compensation plan liabilities⁽⁴⁾		(1,217	)		—		—		(1,217	)

	$	129,359		$	15,739	$	113,805	$	(185	)

⁽¹⁾	Included in cash and cash equivalents and short-term investments on our Condensed Consolidated Balance Sheet. See “Investments” in Note 6 for further details.

⁽²⁾	Included in other current assets and/or other current liabilities on our Condensed Consolidated Balance Sheet. Consisted of forward foreign exchange contracts for the Japanese yen. See “Derivative Instruments and Hedging” in Note 7 for further details.

⁽³⁾	Included in other assets on our condensed consolidated balance sheet.

⁽⁴⁾	Included in other liabilities on our Condensed Consolidated Balance Sheet.

Ultratech, Inc.

Notes to Condensed Consolidated Financial Statements—(Continued)

(Unaudited)

October 2, 2010

(6) Investments

We classified all of our investments as “available for sale” as of October 2, 2010 and December 31, 2009, resepectively. Accordingly, we state our investments at estimated fair value. Fair values are determined based on quoted market prices or pricing models using current market rates. We deem all investments to be available to meet current working capital requirements. The cost of securities sold was determined based on the specific identification method.

The following table summarizes our investments:


	October 2, 2010								December 31, 2009
Cash equivalents and Available- for-sale Investments (in thousands)	Amortized Cost		Accumulated Other Comprehensive				Estimated Fair Value		Amortized Cost		Accumulated Other Comprehensive				Estimated Fair Value
	Amortized Cost		Gains		Losses		Estimated Fair Value		Amortized Cost		Gains		Losses		Estimated Fair Value
Commercial papers	$	13,347	$	—	$	—	$	13,347	$	13,996	$	—	$	—	$	13,996
Money market funds		9,175		—		—		9,175		15,738		—		—		15,738
U.S. corporate debt securities		—		—		—		—		1,186		6		—		1,192
U.S. treasury bills and notes		—		—		—		—		15,203		—		3		15,200
Securities and obligations of U.S. government agencies		121,963		27		65		121,925		83,336		109		106		83,339

Total	$	144,485	$	27	$	65	$	144,447	$	129,459	$	115	$	109	$	129,465

The following table identifies the balance sheet classifications of our investments at October 2, 2010 and at December 31, 2009:


(In thousands)	October 2, 2010		December 31, 2009
Cash equivalents	$	18,523	$	27,741
Short-term investments		125,924		101,724

Investments, at estimated fair value	$	144,447	$	129,465

The gross amortized cost and estimated fair value of our investments at October 2, 2010 and December 31, 2009, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because the issuers of the securities may have the right to prepay obligations without prepayment penalties.


	October 2, 2010				December 31, 2009
(In thousands)	Gross Amortized Cost		Fair Value		Gross Amortized Cost		Fair Value
Due in one year or less	$	134,078	$	134,045	$	125,457	$	125,463
Due after one year through five years		10,407		10,402		4,002		4,002

Total	$	144,485	$	144,447	$	129,459	$	129,465

The following table provides the breakdown of the cash equivalents and investments with unrealized losses at October 2, 2010:


	In Loss Position for Less Than 12 Months				In Loss Position for More Than 12 Months				Total
(In thousands)	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
Securities and obligations of the U.S. government agencies	$	20,495	$	61	$	5,894	$	4	$	26,389	$	65

Total	$	20,495	$	61	$	5,894	$	4	$	26,389	$	65

Ultratech, Inc.

Notes to Condensed Consolidated Financial Statements—(Continued)

(Unaudited)

October 2, 2010

The following table provides the breakdown of the cash equivalents and investments with unrealized losses at December 31, 2009:


	In Loss Position for Less Than 12 Months				In Loss Position for More Than 12 Months				Total
(in thousands)	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
U.S. treasury bills and notes	$	15,200	$	3	$	—	$	—	$	15,200	$	3
Securities and obligations of U.S. government agencies		44,635		106		—		—		44,635		106

Total	$	59,835	$	109	$	—	$	—	$	59,835	$	109

We review our investment portfolio regularly for impairment. A security is considered impaired when its fair value is less than its cost basis. If we intend to sell an impaired debt security or it is more likely than not that we will be required to sell it prior to recovery of its amortized cost basis, an other-than-temporary-impairment (“OTTI”) is deemed to have occurred. In these instances, the OTTI loss is recognized in earnings equal to the entire difference between the debt security’s amortized cost basis and its fair value at the balance sheet date.

If we do not intend to sell an impaired debt security and it is not more likely than not that we will be required to sell it prior to recovery of its amortized cost basis, we must determine whether it will recover its amortized cost basis. If we conclude it will not, a credit loss exists and the resulting OTTI is separated into:

•

The amount representing the credit loss, which is recognized in earnings; and

•

The amount related to all other factors, which is recognized in other comprehensive income.

As part of this assessment we will consider the various characteristics of each security, including, but not limited to the following: the length of time and the extent to which the fair value has been less than the amortized cost basis; adverse conditions specifically related to the security, an industry, or a geographic area; the payment structure of the debt security; failure of the issuer of the security to make scheduled interest or principal payments; any changes to the rating of the security by a rating agency and related outlook or status; recoveries or additional declines in fair value subsequent to the balance sheet date. The relative importance of this information varies based on the facts and circumstances surrounding each security, as well as the economic environment at the time of assessment.

We have not recorded any OTTI of our investments for the three month and nine month periods ended October 2, 2010 and October 3, 2009, respectively.

(7) Derivative Instruments and Hedging

The majority of our revenue, expense and capital purchasing activities are transacted in U.S. dollars. However, we also enter into these transactions in other currencies, primarily Japanese yen as we have direct sales operations in Japan and orders are often denominated in Japanese yen. This subjects us to a higher degree of risk from currency exchange rate fluctuations.

Our policy is to minimize foreign currency denominated transaction and remeasurement exposure with derivative instruments, mainly forward contracts. We enter into foreign currency forward contracts that generally have maturities of nine months or less. The gains and losses on these derivatives are intended to mitigate the translation gains and losses recognized in earnings. We do not enter into foreign exchange forward contracts for speculative purposes.

Under ASC Topic 815, Derivatives and Hedging (“ASC 815”), all derivatives are recorded on the balance sheet at fair value. The gains and losses resulting from changes in fair value are accounted for depending on the use of the derivative and whether it is designated and qualifies for hedge accounting. All of our derivatives are designated as hedging instruments under ASC 815. The fair value of derivative instruments recorded in our Condensed Consolidated Balance Sheets is as follows:


	Asset and Liability Derivatives
		Fair Value as of
(In thousands)	Balance Sheet Location	October 2, 2010			December 31, 2009
Foreign exchange contracts	Other current assets	$	8		$	79
	Other current liabilities	$	(3	)	$	—

Total derivatives		$	5		$	79

Ultratech, Inc.

Notes to Condensed Consolidated Financial Statements—(Continued)

(Unaudited)

October 2, 2010

Our derivative financial instruments are subject to both credit and market risk. Credit risk is the risk of loss due to failure of a counterparty to perform its obligations in accordance with contractual terms. Market risk is the potential change in an investment’s value caused by fluctuations in interest and currency exchange rates, credit spreads or other variables. We monitor the credit-worthiness of the financial institutions that are counterparties to our derivative financial instruments and do not consider the risks of counterparty nonperformance to be material. Credit and market risks related to derivative instruments were not considered material at October 2, 2010 and December 31, 2009, respectively, as a result of an offset by the underlying cash flow being hedged.

Cash Flow Hedging

We use foreign exchange forward contracts to hedge the risk that forecasted revenue may be adversely affected by changes in foreign currency exchange rates. These hedges are designated as cash flow hedges. We do not enter into these forward contracts for speculative purposes. The effective portion of the contracts’ gains or losses is included in accumulated other comprehensive income (loss) (“OCI”) until the period in which the forecasted sale being hedged is recognized, at which time the amount in OCI is reclassified to earnings as a component of revenue.

To the extent that any of these contracts are not considered to be effective in offsetting the change in the value of the forecasted sales being hedged, the ineffective portion of these contracts is immediately reclassified from OCI and recognized in the consolidated statement of operations as a component of interest and other income (expense), net. The contracts are considered ineffective when the underlying forecasted transaction does not occur within the designated hedge period or it becomes probable that the forecasted transaction will not occur.

We calculate hedge effectiveness at a minimum each fiscal quarter. We measure hedge effectiveness by comparing the cumulative change in the spot rate of the derivative with the cumulative change in the spot rate of the anticipated sales transactions. We record any excluded components of the hedge in interest and other income (expense), net. There was no hedge ineffectiveness for the three months ended October 2, 2010, and we did not have any derivatives classified as cash flow hedges outstanding at October 2, 2010 and December 31, 2009. As such, we did not record any accumulated losses or gains as a component of other comprehensive income (loss) at October 2, 2010 or December 31, 2009. The following sets forth the effect of the derivative instruments on our Condensed Consolidated Statements of Operations for the nine month period ended October 3, 2009:

Derivatives in SFAS No. 133
Cash Flow Hedging Relationship

Amount of Loss
Recognized in OCI
on Derivative
(Effective Portion)
(in thousands)

Location of Loss
Reclassified from
Accumulated OCI
into Income
(Effective Portion)

Amount of Loss
Reclassified from
Accumulated OCI
into Income
(Effective Portion)
(in thousands)

Location of Gain
Recognized in Income
on Derivative (Amount
Excluded from
Effectiveness Testing)

Amount of Gain
Recognized in
Income on
Derivative (Amount
Excluded from
Effectiveness Testing)
(in thousands)

Foreign exchange
contracts

$ 40

Product Sales

Interest and other
income (expense), net

Ultratech, Inc.

Notes to Condensed Consolidated Financial Statements—(Continued)

(Unaudited)

October 2, 2010

Fair Value Hedging

We manage the foreign currency risk associated with Japanese yen denominated assets and liabilities using foreign exchange forward contracts. The change in fair value of these derivatives is recognized as a component of interest and other income (expense), net, and is intended to offset the remeasurement gains and losses associated with the non-functional currency denominated assets and liabilities. At October 2, 2010, we had currency forward contracts for the sale of 69.4 million Japanese yen, or approximately $0.8 million. The fair value of derivatives classified as balance sheet hedges at October 2, 2010 was immaterial. The following sets forth the effect of the derivative instruments on our Condensed Consolidated Statements of Operations for the three month and nine month periods ended October 2, 2010 and October 3, 2009, respectively:


		Amount of Gain (Loss) Recognized in Income on Derivatives During
Derivatives in ASC 815 Fair Value Hedging Relationship	Location of Gain (Loss) Recognized in Income on Derivatives	The three months ended, October 2, 2010 (in thousands)			The nine months ended, October 2, 2010 (in thousands)
Foreign exchange contracts	Interest and other income (expense), net	$	5		$	(65	)

		Amount of Gain (Loss) Recognized in Income on Derivatives During
Derivatives in ASC 815 Fair Value Hedging Relationship	Location of Gain (Loss) Recognized in Income on Derivatives	The three months ended, October 3, 2009 (in thousands)			The nine months ended, October 3, 2009 (in thousands)
Foreign exchange contracts	Interest and other income (expense), net	$	(59	)	$	172

(8) Inventories

Inventories consist of the following:


(In thousands)	October 2, 2010		December 31, 2009
Raw materials	$	15,579	$	9,739
Work-in-process		11,357		5,342
Finished products		7,020		10,800

	$	33,956	$	25,881

(9) Notes Payable

We have a line of credit agreement with a brokerage firm. Under the terms of this agreement, we may borrow funds at a cost equal to the current Federal funds open rate plus 125 basis points (approximately 1.45% as of October 2, 2010). Funds are advanced to us under this facility based on pre-determined advance rates on the cash and securities held by us in this brokerage account. Under this facility, we may borrow up to 75% of our total cash, cash equivalents and investments balance in this brokerage account with no restriction in the use of those assets. This agreement has no set expiration date and there are no loan covenants, other than the aforementioned collateral requirement. As of October 2, 2010 and as of December 31, 2009, $6.0 million was outstanding under this facility, with a related collateral requirement of approximately $8.0 million of our cash, cash equivalents and investments.

(10) Other Current Liabilities

Other current liabilities consist of the following:


(In thousands)	October 2, 2010		December 31, 2009
Salaries and benefits	$	6,162	$	3,753
Warranty accrual		2,476		1,710
Accrued taxes-other		432		288
Capital lease, current portion		126		120
Advanced billing		2,006		50
Other		597		799

	$	11,799	$	6,720

Warranty Accrual

We generally warrant our products for material and labor to repair the product for a period of twelve months for new products, or three months for refurbished products, for material and labor to repair the product from the date of customer acceptance. Accordingly, an accrual for the estimated cost of the warranty is recorded at the time the product is shipped. Extended warranty terms, if granted, result in deferral of revenue equating to our standard pricing for similar service contracts. Recognition of the related warranty cost is deferred until product revenue is recognized. Factors that affect our

Ultratech, Inc.

Notes to Condensed Consolidated Financial Statements—(Continued)

(Unaudited)

October 2, 2010

warranty liability include the number of installed units, historical and anticipated rates of warranty claims, and cost per claim. We periodically assess the adequacy of our recorded warranty liabilities and adjust the amounts as necessary. We believe our warranty accrual, as of October 2, 2010, is sufficient to satisfy outstanding obligations as of that date. Changes in our warranty accrual are as follows:


	Three Months Ended						Nine Months Ended
(In thousands)	October 2, 2010			October 3, 2009			October 2, 2010			October 3, 2009
Balance, beginning of the period	$	2,120		$	995		$	1,710		$	1,522
Warranties accrued for shipments during the period		1,140			287			2,433			911
Settlements made during the period		(376	)		(479	)		(900	)		(1,798	)
Changes in accrued warranty liabilities		(408	)		91			(767	)		259

Balance, end of the period	$	2,476		$	894		$	2,476		$	894

Deferred Services Revenue

A portion of our revenue is generated from service contracts. Payments from certain of these service contracts are collected in advance. As such, revenues from these service contracts are deferred and recognized ratably over the contract period for time based service contracts, or as service hours are delivered for contracts based on a purchased quantity of hours. Changes in our deferred service revenue are as follows:


	Three Months Ended						Nine Months Ended
(In thousands)	October 2, 2010			October 3, 2009			October 2, 2010			October 3, 2009
Balance, beginning of the period	$	2,257		$	1,942		$	1,907		$	2,117
Service contracts sold during the period		925			854			2,500			2,156
Service contract revenue recognized during the period		(879	)		(831	)		(2,104	)		(2,308	)

Balance, end of the period	$	2,303		$	1,965		$	2,303		$	1,965

(11) Other Liabilities

Other liabilities consist of the following:


(In thousands)	October 2, 2010		December 31, 2009
Deferred rent	$	192	$	781
Deferred compensation		1,136		1,217
Long-term income taxes payable		697		670
Asset retirement obligation		1,432		2,162
Postretirement medical obligation		642		616
Long-term capital lease		169		265
Other		7		224

	$	4,275	$	5,935

Pursuant to the terms of the lease amendment signed in October 2009, in consideration for the waiver of certain asset retirement obligations set forth in the original lease of a building in San Jose, California, we paid the landlord $0.6 million and surrendered possession of the premises on March 31, 2010.

Ultratech, Inc.

Notes to Condensed Consolidated Financial Statements—(Continued)

(Unaudited)

October 2, 2010

(12) Accumulated Other Comprehensive Income (Loss)

The components of comprehensive income (loss), net of tax, are as follows:


	Three Months Ended						Nine Months Ended
(In thousands)	October 2, 2010			October 3, 2009			October 2, 2010			October 3, 2009
Net income	$	4,902		$	1,041		$	10,467		$	745
Other comprehensive income:
Unrealized loss on available-for-sale investments		(15	)		(161	)		(44	)		(509	)

Net unrealized loss on available-for-sale investments		(15	)		(161	)		(44	)		(509	)
Unrealized gain on foreign exchange forward contracts		—			—			—			84
Change in minimum postretirement medical obligation		15			15			45			89

Comprehensive income	$	4,902		$	895		$	10,468		$	409

Accumulated other comprehensive loss, net of tax, is comprised of the following items:


(In thousands)	October 2, 2010			December 31, 2009
Unrealized gain (loss) on:
Available-for-sale investments	$	(38	)	$	6
Change in minimum postretirement medical obligation		1			(44	)

Accumulated other comprehensive loss at end of period	$	(37	)	$	(38	)

(13) Exit Activities

We did not have any exit activity during the three month and nine month periods ended October 2, 2010, respectively. As a result there were no exit activity liabilities as of October 2, 2010.


(In thousands)	Balance at December 31, 2009		Expenses		Payments			Balance at October 2, 2010
Severance and benefits (fiscal year 2009)	$	—		576		(576	)		—
Severance and benefits (fiscal year 2010)		—		—		—			—

Total	$	—	$	576	$	(576	)	$	—

During the first quarter of 2009, in an effort to reduce company-wide expenses, we eliminated 21 full-time positions, 90% in the United States and 10% internationally. We recorded severance and benefits charges totaling $0.6 million during the nine month period ended October 3, 2009. Of this $0.6 million, $0.3 million was recorded as research, development and engineering expenses, $0.2 million as cost of sales and the remaining $0.1 million as selling, general and administrative expenses. As of October 3, 2009, there were no exit activity liabilities.

(14) Employee Benefit Plans

Employee bonus plans

We currently sponsor an executive incentive bonus plan that distributes employee awards based on the achievement of predetermined targets. We recorded a charge of $0.8 million and $2.6 million under this bonus plan for the three month and nine month periods ended October 2, 2010, respectively, as compared to $0.2 and $0.4 million, respectively, for the corresponding periods of 2009.

Ultratech, Inc.

Notes to Condensed Consolidated Financial Statements—(Continued)

(Unaudited)

October 2, 2010

Employee savings and retirement plans

We sponsor a 401(k) employee salary deferral plan that allows voluntary contributions by all full-time employees of from 1% to 20% of their pretax earnings. We may also make matching contributions to this plan at our discretion. Our contributions, when made, are limited to a maximum of $2,000 per year per employee, generally become 20% vested at the end of an employee’s first year of service from the date of hire, and vest 20% per year of service thereafter until they become fully vested at the end of five years of service. We did not make any contributions to this plan for the three month and nine month periods ended October 2, 2010 and October 3, 2009, respectively.

We also sponsor an executive non-qualified deferred compensation plan (the “Plan”) that allows qualifying executives to defer current cash compensation. As of October 2, 2010, Plan assets of $0.9 million, representing the cash surrender value of life insurance policies held by us, and liabilities of $1.1 million were included in our Condensed Consolidated Balance Sheets under the captions “Other assets” and “Other liabilities”, respectively. The related Plan expenses for each of the three month periods ended October 2, 2010 and October 3, 2009, respectively, were immaterial.

Ultratech, Inc.

Notes to Condensed Consolidated Financial Statements—(Continued)

(Unaudited)

October 2, 2010

Postretirement benefits

We have committed to providing and fully paying for lifetime postretirement medical and dental benefits to our Chief Executive Officer and Chief Financial Officer and their spouses, commencing after retirement. We recorded net periodic benefit costs of $24,000 and $68,000 for the three month and nine month periods ended October 2, 2010, respectively, as compared to $23,000 and $0.1 million for each of the three month and nine month periods ended October 3, 2009, respectively. These expenses included interest cost and amortization of prior service cost.

(15) Income Taxes

In accordance with FASB ASC Topic 740, Income Taxes (“ASC 740”), we had unrecognized tax benefits of $3.4 million as of January 1, 2010. We continue to recognize interest and penalties as a component of the income tax provision. If we are able to eventually recognize these uncertain tax positions, $2.9 million of our unrecognized benefit would reduce the effective tax rate. Over the next twelve months, we expect an immaterial decline in liabilities associated with our uncertain tax positions as a result of expiring statutes of limitations.

We currently have a full valuation allowance against our U.S. net deferred tax asset. Each quarter we assess the likelihood that we will be able to recover our deferred tax assets. As a result of our analysis, we concluded that it is more likely than not that, as of October 2, 2010, our net deferred tax assets will not be realized, with the exception of those in Japan and Taiwan. Therefore, we continue to provide a full valuation allowance against net deferred tax assets outside of Japan and Taiwan. We closely monitor available evidence, and may release some or all of the valuation allowance in future periods.

We are subject to federal and state tax examinations for years 1994 forward and 1997 forward, respectively, by virtue of the tax attributes carrying forward from those years. We are also subject to audits in the foreign jurisdictions in which we operate for years 2001 and forward. There are no material income tax audits currently in progress as of October 2, 2010.

(16) Commitments and Contingencies

Commitments

In March 2010, the Company entered into a building lease agreement in preparation for the expansion of our manufacturing operations in Singapore. The initial term of the lease is three years, and is accounted for as an operating lease.

In July 2007, we capitalized a five-year lease agreement for a new phone system recorded as office equipment. The amortization of this phone system is included with depreciation expense.

In August 2008 and December 2009, we entered into agreements with a leasing company for the sale and leaseback of certain assets for an initial term of four years. The sale price of the items was $6.8 million in 2008 and $5.4 million in 2009 for the sale in 2008 and 2009, respectively. There was no gain or loss from this transaction. Under this sale-leaseback arrangement, we have an option to purchase the assets back at the future current fair market value upon the expiration of the lease in 2012 and 2013, respectively. These leases are classified as operating leases in accordance with ASC Topic 840, Leases. In January 2009, we bought back assets with values totaling $1.3 million. We did not buy back any assets during the three month period ended October 2, 2010. In April 2010, we bought back an asset with a value of $1.2 million. As of October 2, 2010, the minimum future lease payments to be made under these agreements were $3.9 million.

In October 2009, we entered into two lease amendments for our facilities in San Jose, California. The first lease amendment extended one of the building leases for five years. This lease extension will expire in January 2016. We account for this lease as an operating lease; any improvements to the leased property are capitalized and classified as leasehold improvements. Pursuant to the terms of the second lease amendment, in consideration for the waiver of certain surrender obligations set forth in the original lease of a separate building, we paid the landlord $0.6 million and surrendered possession of the premises on March 31, 2010.

Legal Proceedings

Ultratech, Inc.

Notes to Condensed Consolidated Financial Statements—(Continued)

(Unaudited)

October 2, 2010

reimbursement of its attorneys’ fees and costs in a total asserted amount of approximately $2 million. We opposed this motion, and on October 12, 2005, the District Court denied the defendant’s request for attorneys’ fees in its entirety. The defendant appealed that decision. On November 3, 2005, the defendant filed a notice of appeal with respect to the court’s ruling on its motion for attorneys’ fees. In March 2006, the Federal Circuit court upheld the district court’s ruling that the subject patent is invalid. On August 8, 2006, the Federal Circuit court upheld the District Court’s denial of attorneys’ fees. Neither side appealed the rulings by the Federal Circuit.

In May 2006, the same company filed a state court lawsuit against us for malicious prosecution and abuse of process claiming that attorney’s fees, costs and other damages were due based on the outcome of the federal patent litigation suit described above. We do not believe this action has merit, particularly given the denial by the federal court of that company’s request to be awarded attorneys’ fees payable by us in the patent litigation and the subsequent federal appellate court’s affirmation of the order denying any such award. We filed a motion to have the state court complaint dismissed under California’s anti-strategic lawsuit against public participation (“anti-SLAPP”) and demurrer statutes. The anti-SLAPP statute is aimed at striking lawsuits that are brought in order to quash an individual’s constitutional rights to free speech or seeking redress of grievances (i.e., filing suit). The state court granted the anti-SLAPP motion as to the abuse of process claim, but denied it as to the malicious prosecution claim. Our subsequent appeals to the appellate court and California Supreme Court were unsuccessful, and the matter has returned to Riverside County Superior Court. We moved for summary judgment on the matter based on federal preemption, but the Superior Court denied the motion. A subsequent writ of mandamus filed by us was also not successful. Trial in the matter is now set for January 31, 2011.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Certain of the statements contained herein, which are not historical facts and which can generally be identified by words such as “anticipates,” “expects,” “intends,” “will,” “could,” “believes,” “estimates,” “continues,” and similar expressions, are forward-looking statements under Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that involve risks and uncertainties, such as risks related to timing, delays, deferrals and cancellations of orders by customers, including as a result of semiconductor manufacturing capacity as well as our customers’ financial condition and demand for semiconductors; cyclicality in the semiconductor and nanotechnology industries; general economic and financial market conditions including impact on capital spending, as well as difficulty in predicting changes in such conditions; rapid technological change and the importance of timely product introductions; customer concentration; our dependence on new product introductions and market acceptance of new products and enhanced versions of our existing products; lengthy sales cycles, including the timing of system installations and acceptances; lengthy and costly development cycles for laser-processing and lithography technologies and applications; integration, development and associated expenses of the laser processing operation; pricing pressures and product discounts; high degree of industry competition; intellectual property matters; changes in pricing by us, our competitors or suppliers; international sales; timing of new product announcements and releases by us or our competitors; ability to volume produce systems and meet customer requirements; sole or limited sources of supply; effect of capital market fluctuations on our investment portfolio; ability and resulting costs to attract or retain sufficient personnel to achieve our targets for a particular period; dilutive effect of employee stock option grants on net income per share, which is largely dependent upon our achieving and maintaining profitability and the market price of our stock; mix of products sold; outcome of litigation; manufacturing variances and production levels; timing and degree of success of technologies licensed to outside parties; product concentration and lack of product revenue diversification; inventory obsolescence; asset impairment; changes to financial accounting standards; effects of certain anti-takeover provisions; future acquisitions; volatility of stock price; foreign government regulations and restrictions; business interruptions due to natural disasters or utility failures; environmental regulations; and any adverse effects of the public health issues, wars or terrorist attacks in the United States or elsewhere, or government responses thereto, or military actions in Iraq, Afghanistan and elsewhere, on the economy in general, or on our business in particular. Due to these and additional factors, the statements, historical results and percentage relationships set forth below are not necessarily indicative of the results of operations for any future period. These forward-looking statements are based on management’s current beliefs and expectations, some or all of which may prove to be inaccurate, and which may change. We undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date of this report.

OVERVIEW

We develop, manufacture and market photolithography and laser thermal processing equipment for manufacturers of integrated circuits and nanotechnology components located throughout North America, Europe, Japan, Taiwan and the rest of Asia.

RESULTS OF OPERATIONS

We derive a substantial portion of our total net sales from sales of a relatively small number of newly manufactured systems, which typically range in price from $1.0 million to $6.0 million. As a result of these high sale prices, the timing and recognition of revenue from a single transaction has had and most likely will continue to have a significant impact on our net sales and operating results for any particular period.

Our backlog at the beginning of a period typically does not include all of the sales needed to achieve our sales objectives for that period. In addition, orders in backlog are subject to cancellation, shipment or customer acceptance delays, and deferral or rescheduling by a customer with limited or no penalties. Consequently, our net sales and operating results for a period have been and will continue to be dependent upon our obtaining orders for systems to be shipped and accepted in the same period in which the order is received. Our business and financial results for a particular period could be materially adversely affected if an anticipated order for even one system is not received in time to permit shipment and customer acceptance during that period. Furthermore, a substantial portion of our shipments has historically occurred near the end of each quarter. Delays in installation and customer acceptance due, for example, to our inability to successfully demonstrate the agreed-upon specifications or criteria at the customer’s facility, or to the failure of the customer to permit installation of the system in the agreed upon time, may cause net sales in a particular period to fall significantly below our expectations, which may materially adversely affect our operating results for that period. This risk is especially applicable in connection with the introduction and initial sales of a new product line. Additionally, the failure to receive anticipated orders or delays in shipments due, for example, to rescheduling, delays, deferrals or cancellations by customers, additional customer configuration requirements, or to unexpected manufacturing difficulties or delays in deliveries by suppliers due to their long production lead times or otherwise, have caused and may continue to cause net sales in a particular period to fall significantly below our expectations, materially adversely affecting our operating results for that period. In particular, the long manufacturing and acceptance cycles of our advanced packaging family of wafer steppers and laser thermal processing systems and the long lead time for lenses and other materials, could cause shipments and acceptances of such products to be delayed from one quarter to the next, which could materially adversely affect our financial condition and results of operations for a particular quarter.

Additionally, the need for continued expenditures for research and development, capital equipment, ongoing training and worldwide customer service and support, among other factors, will make it difficult for us to reduce our operating expenses in a particular period if we fail to achieve our net sales goals for the period.

Net Sales

Third Quarter


	Three Months Ended
(In thousands, except percentages)	October 2, 2010		October 3, 2009		Amount of Change		Percentage Change
Sales of:
Products	$	33,814	$	21,050	$	12,764		60.6	%
Services		3,998		3,889		109		2.8	%
Licenses		125		—		125		*

Total net sales	$	37,937	$	24,939	$	12,998		52.1	%

*	Not Meaningful

Net sales consist of revenues from products (system, system upgrades, and spare parts sales), services, and licensing of technologies. Product sales increased 60.6% to $33.8 million for the three month period ended October 2, 2010, compared to $21.1 million in the corresponding quarter of 2009. The increase was due to (i) increased systems sales of $11.8 million and (ii) increased systems upgrades of $1.0 million as compared to the corresponding periods of 2009. The increase in product revenue was a result of unit increases in our laser processing tools.

On a product market application basis, systems sales to the semiconductor industry increased $12.7 million to $30.8 million for the three month period ended October 2, 2010, as compared to $18.1 million in the corresponding quarter of 2009. Semiconductor industry sales consist of sales to the advanced packaging market, the laser processing applications market and the semiconductor market.

There were no system sales to the nanotechnology market for the three months period ended October 2, 2010 and October 3, 2009, respectively. System sales to the nanotechnology market are highly dependent on customer capacity demand in the industries we serve, including thin film heads, automotive MEMS, LED/laser diodes, and ink jet print heads, and therefore we expect to experience significant variations in sales to this market from quarter to quarter.

Service sales for the three months ended October 2, 2010 remained relatively flat at $4.0 million, as compared $3.9 million during the same period of 2009.

License sales consisted of $0.1 million of royalty revenues for the three months ended October 2, 2010 as compared to no royalty revenue for the corresponding quarter of October 3, 2009. License revenue fluctuations are due to the timing and frequency of tool resales by our existing customers to third parties and from royalty arrangements. Pursuant to our license arrangements, such transactions are subject to a license fee based on units sold. Future revenues from licensing activities, if any, will be contingent upon existing and future licensing arrangements. We may not be successful in generating licensing revenues in the future and do not anticipate the recognition of significant levels of licensing income during the remainder of 2010.

At October 2, 2010, the Company had $16.0 million of net deferred product and services income compared to $8.8 million at December 31, 2009. The gross amount of deferred revenues at October 2, 2010 was $24.3 million as compared to $13.4 million at December 31, 2009. The gross amount of deferred costs at October 2, 2010 was $8.3 million as compared to $4.6 million at December 31, 2009. Deferred product income is recognized as revenue upon satisfying the contractual obligations for installation and/or customer acceptance. Deferred services income is recognized as revenue ratably over the contract period (for time-based service contracts), or as purchased services are rendered (for contracts based on a purchased quantity of hours).

For the three months ended October 2, 2010, international net sales were $29.8 million, or 78.5% of total net sales, compared with $21.7 million, or 86.8% of total net sales for the corresponding quarter of 2009. For the three months ended October 2, 2010 compared to the corresponding 2009 quarter, sales to Europe increased by $8.0 million, sales to Japan decreased by $0.1 million, sales to Taiwan increased by $1.2 million, sales to Korea increased by $5.2 million, and sales to the rest of Asia decreased by $6.2 million.

Our international revenue generally is not subject to significant exchange rate fluctuations, principally because sales contracts for our systems are mainly denominated in U.S. dollars. In Japan, however, orders are sometime denominated in Japanese yen. Yen denominated contracts subjects us to the risk of currency fluctuations. We attempt to mitigate this risk by entering into foreign currency forward exchange contracts for the period between when an order is received and when it is recorded as revenue. After recording revenue, we use various mechanisms such as natural hedges to offset substantial portions of the gains or losses associated with our Japanese yen denominated receivables due to exchange rate fluctuations. We had approximately 33.2 million Japanese yen denominated receivables at October 2, 2010. International sales expose us to a number of additional risks, including fluctuations in the value of local currencies relative to the U.S. dollar, which impact the relative cost of ownership of our products and, thus, the customer’s willingness to purchase our product. (See Part II, Item 1A, “Risk Factors” herein).

Year-To-Date


	Nine Months Ended
(In thousands, except percentages)	October 2, 2010		October 3, 2009		Amount of Change		Percentage Change
Sales of:
Products	$	85,419	$	58,177	$	27,242		46.8	%
Services		11,322		10,931		391		3.6	%
Licenses		250		82		168		204.9	%

Total net sales	$	96,991	$	69,190	$	27,801		40.2	%

Product sales increased 46.8% to $85.4 million for the nine month period ended October 2, 2010 as compared to the same period in 2009. The increase was due to (i) increased systems sales of $24.4 million, (ii) $2.5 million more in systems upgrades, and (iii) $0.3 million more in spare parts. The increase in product revenue was a result of unit increases in the semiconductor and laser processing market and higher average selling prices for the advanced packaging market.

On a market basis during the nine months ended October 2, 2010, system sales to the semiconductor industry increased by $24.4 million to $74.1 million from the corresponding period of 2009. This increase was due to (i) a $19.6 million increase in sales to the laser processing market, (ii) a $3.4 million increase in sales to the advanced packaging market, and (iii) a $1.7 million increase in sales to the semiconductor market partially offset by a $0.2 million decrease in sales to the nanotechnology market.

Service revenue during the nine months ended October 2, 2010 increased $0.4 million or 3.6% from the comparable period of 2009. Revenues from licensing activities increased in the nine months ended October 2, 2010 as compared to the same period of 2009. During the nine month period ending October 3, 2010 there was $0.3 million licensing revenue associated with our royalty arrangements as compared with $0.1 million for the same period of 2009.

For the nine months ended October 2, 2010, international net sales were $74.0 million, or 76.4% of total net sales, as compared with $45.2 million, or 65.3% of total net sales, for the comparable period of 2009. For the nine months ended October 2, 2010, as compared to the same period of 2009, the $28.9 million increase in international revenue was due to (i) increased sales to Taiwan of $12.4 million, (ii) increased sales to Korea of $15.6 million, and (iii) increased sales to Europe of $15.4 million which were partially offset by decreased sales to Japan of $4.5 million and decreased sales to the rest of Asia of $10.0 million.

Gross Profit

On a comparative basis, gross margins decreased to 48.8% for the three month period ended October 2, 2010, compared to 50.4% for the corresponding period of 2009. This 1.6 percentage point decrease in gross margin was due to (i) a 5.4 percentage point decrease from product mix, (ii) a 4.5 percentage point increase from system volume increases, and (iii) a 0.7 percentage point decrease related to increased expenses primarily resulting from additional manufacturing labor and consumable materials.

Gross margin for the nine month period ended October 2, 2010 increased to 50.8% compared to 46.4% in the corresponding quarter of 2009. This 4.4 percentage point increase was due to (i) a 4.2 percentage point increase in sales volume, and (ii) a 0.2 percentage point increase from decreased service costs.

Our gross profit as a percentage of sales has been and most likely will continue to be significantly affected by a variety of factors, including the following: the introduction of new products, which typically have higher manufacturing costs until manufacturing efficiencies are realized and which are typically discounted more than existing products until the products gain market acceptance; the mix of products sold; the rate of capacity utilization; write-down of inventory and open purchase commitments; product discounts, pricing and competition in our targeted markets; non-linearity of shipments during the quarter which can result in manufacturing inefficiencies; and the percentage of international sales, which typically have lower gross margins than domestic sales principally due to higher field service and support costs.

Operating Expenses

Third Quarter


	Three Months Ended
(In thousands, except percentages)	October 2, 2010		October 3, 2009		Amount of Change		Percentage Change
Research, development, and engineering	$	4,980	$	4,573	$	407		8.9	%
Selling, general, and administrative		8,634	$	7,262		1,372		18.9	%

Total operating expenses	$	13,614	$	11,835	$	1,779		15.0	%

Research, development and engineering expenses for the three month period ended October 2, 2010 were $5.0 million, as compared to $4.6 million for the corresponding period in 2009. This increase was primarily attributable to an additional $0.2 million of salary expenses and outside service costs, as compared to the corresponding quarter in 2009. As a percentage of net sales, research, development and engineering expenses for the three month period ended October 2, 2010 decreased to 13.1% from 18.3% for the corresponding quarter of 2009. This percentage decrease was due to the increase in net sales as compared to the corresponding quarter of 2009.

Selling, general, and administrative expenses for the three month period ended October 2, 2010 were $8.6 million as compared to $7.3 million for the corresponding quarter of 2009. This increase was mostly attributable to (i) $0.4 million of bonus expense related to our executive incentive bonus plan, (ii) $0.4 million in stock-based compensation expense, and (iii) $0.6 million in other travel and professional service expenses related to our international sales offices. As a percentage of net sales, selling, general and administrative expenses for the three months ended October 2, 2010 decreased to 22.8% from 29.1% for the corresponding quarter of 2009. This percentage decrease was due to the increase in net sales as compared to the corresponding quarter of 2009.

Year-To-Date


	Nine Months Ended
(In thousands, except percentages)	October 2, 2010		October 3, 2009		Amount of Change		Percentage Change
Research, development, and engineering	$	14,610	$	14,208	$	402		2.8	%
Selling, general, and administrative		24,091		20,186		3,905		19.3	%

Total operating expenses	$	38,701	$	34,394	$	4,307		12.5	%

Research, development and engineering expenses were $14.6 million and $14.2 million for the nine month periods ended October 2, 2010 and October 3, 2009, respectively. The $0.4 million increase was primarily related to compensation expense. As a percentage of net sales, research, development and engineering expenses for the nine month period ended October 2, 2010 decreased to 15.1% from 20.5% for the corresponding period of 2009. This percentage decrease was due to the increase in net sales as compared to the corresponding quarter of 2009.

Selling, general and administrative expenses were $24.1 million for the nine month period ended October 2, 2010 as compared with $20.2 million for the corresponding period in 2009. The $3.9 million increase was due to the following: (i) a $2.2 million increase in executive bonus plan expense, (ii) $1.1 million of stock-based compensation expenses, and (iii) $0.6 million of other miscellaneous expense items. As a percentage of total net sales, selling, general and administrative expenses for the nine month period ended October 2, 2010 decreased to 24.8% from 29.2% for the corresponding period of 2009. This decrease was due to the increase in net sales as compared to the corresponding quarter of 2009 discussed above.

Interest and Other Income (Expense), Net

Interest and other income (expense), net, which consists primarily of interest income and gain (loss) from foreign currency exchange, was a net income of $0.1 million and $0.3 million for the three and nine month periods ended October 2, 2010, respectively. In comparison, interest and other income (expense), net for the three and nine month periods ended October 3, 2009 were $0.3 million and $3.0 million, respectively. The decrease in interest and other income (expense), net in the nine month period ended October 2, 2010 compared to the same period of 2009 is primarily attributable to the recognition in the nine month period ended October 3, 2009 of foreign consumption tax incentive totaling $2.5 million.

The foreign consumption tax incentive related to a benefit we received in fiscal years 2004 and 2005 and was previously reserved due to uncertainties as to the ultimate realization of the incentive. We have determined that those uncertainties have been sufficiently reduced to allow recognition of the benefit. We do not expect to recognize any additional benefit with respect to this tax incentive.

The cost of securities sold was determined based on the specific identification method. As of October 2, 2010, the weighted-average maturity of our investment portfolio was less than a year. Changes in interest rates have had, and will continue to have, an impact on our interest income.

Provision (Benefits) for Income Taxes

For the three month and nine month periods ended October 2, 2010, we recorded an income tax provision of $0.1 million and $0.3 million, respectively, as compared to $1,000 and $37,000 of tax benefits for the comparable periods in 2009. The income tax provision recognized for the three month and nine month periods ended October 2, 2010 resulted primarily from foreign and federal income taxes. Income tax estimates can be affected by whether and within which jurisdictions future earnings will occur and how and when cash is repatriated to the United States, as well as other aspects of an overall income tax strategy. Additionally, taxing jurisdictions could retroactively disagree with our tax treatment of certain items, and some historical transactions have income tax effects going forward. Accounting rules require these future effects to be evaluated using current laws, rules and regulations, each of which can change at any time and in an unpredictable manner. We believe we have adequately provided for any reasonably foreseeable outcome related to these matters, and we do not anticipate any material earnings impact from their ultimate resolution.

Each quarter we assess the likelihood that we will be able to recover our deferred tax assets. We consider available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income and ongoing prudent and feasible tax planning strategies in assessing the need for the valuation allowance. As a result of our analysis, we concluded that it is more likely than not that, as of October 2, 2010, our net deferred tax assets will not be realized, with the exception of those in Japan and Taiwan. Therefore, we continue to provide a full valuation allowance against net deferred tax assets outside of Japan and Taiwan. We closely monitor available evidence, and may release some or all of the valuation allowance in future periods.

We are subject to federal and state tax examination for years 1994 forward and 1997 forward, respectively, by virtue of the tax attributes carrying forward from those years. We are also subject to audits in the foreign jurisdictions in which we operate for years 2001 and forward. There were no material income tax audits currently in progress as of October 2, 2010.

Outlook

We anticipate that both the sequential quarterly revenue growth and our ongoing expense containment program will continue in fourth quarter of 2010. The fourth quarter sequential revenue is expected to approximate 5%-10%. Based on the expected product mix, gross margin should approximate 50%. We estimate earnings per share for the fourth quarter should have sequential growth of about 10%- 15%. We expect the fourth quarter 2010 cash flow to be positive.

Because our net sales are subject to a number of risks, including risks associated with the growth of market acceptance of our new laser processing product line, delays in customer acceptance, intense competition in the capital equipment industry, uncertainty relating to the timing and market acceptance of our products, and the condition of the macro-economy and the semiconductor industry and the other risks described in this report and in our Annual Report on Form 10-K for the year ended December 31, 2009, we may not exceed or even maintain our current or prior level of net sales for any period in the future. Additionally, we believe that the market acceptance and volume production of our advanced packaging systems, laser processing systems and our 1000 Platform steppers are of critical importance to our future financial results. At October 2, 2010, these critical systems represented approximately 88.1% of our backlog. To the extent that these products do not achieve or maintain significant sales due to difficulties involving manufacturing or engineering, the inability to reduce the current long manufacturing cycles for these products, competition, excess capacity in the semiconductor or nanotechnology device industries, or for any other reason, our business, financial condition and results of operations would be materially adversely affected.

We expect that sales to international customers will continue to represent a significant portion of our revenues during fiscal 2010.

LIQUIDITY AND CAPITAL RESOURCES

Net cash provided by operating activities was $24.8 million for the nine months ended October 2, 2010, compared with $7.4 million of cash used by operations for the comparable period in 2009. Net cash provided by operating activities during the nine months ended October 2, 2010 was attributable to (i) $16.4 million of cash from operations activities after non-cash adjustments and (ii) an $8.4 million net cash provided by changes in our working capital.

Changes in working capital inflows were due to (i) accounts receivable collections efforts of $1.1 million, (ii) timing of vendor payments in accounts payable for $8.0 million, (iii) timing differences between shipments to customers and revenue recognition acceptances from deferred income of $7.1 million and (iv) timing of other payments and accruals in other current and non-current liabilities of $3.3 million.

Working capital outflows were due to (i) purchases of raw material inventories to meet production needs of $8.1 million and (ii) other accounts receivable, prepaid expenses, and other assets of $3.0 million.

We believe that because of the relatively long manufacturing cycle of certain of our systems, particularly newer products, our inventories will continue to represent a significant portion of working capital. Currently, we devote significant resources to the commercialization of our laser processing systems and to the development of our next generation 1X lithography technologies. We currently intend to continue to incur significant operating expenses in the areas of research, development and engineering, manufacturing, and selling, general and administrative costs in order to further develop, produce and support these new products. Additionally, gross profit margins, inventory and capital equipment levels may be adversely impacted in the future by costs associated with the production of our laser processing systems and by future generations of our 1X wafer steppers. These costs include, but are not limited to, additional manufacturing overhead, costs of demonstration systems and facilities and the establishment of additional after-sales support organizations. Moreover, there can be no assurance that operating expenses will not increase, relative to sales, as a result of adding technical, marketing and administrative personnel, among other costs, to support our new products. If we are unable to achieve significantly increased net sales or if our sales fall below expectations, our cash flow and operating results will be materially adversely affected until, among other factors, costs and expenses can be reduced. Our failure to achieve our sales targets for these new products could result in inventory write-offs and asset impairment charges, either of which could materially adversely impact our results of operations.

During the nine month period ended October 2, 2010, net cash used in investing activities was $29.0 million, attributable to net purchase of short-term investments of $24.4 million and capital expenditures of $4.7 million primarily related to our expansion in Singapore.

Net cash provided by financing activities was $4.4 million during the nine months ended October 2, 2010, primarily attributable to proceeds from the issuance of common stock for the exercise of 336,563 employee stock options. The exercised stock options had a weighted average exercise price per share of $13.12. There were no other stock issuances for the nine month period ending October 2, 2010.

At October 2, 2010, the Company had working capital of $206.8 million. Our principal sources of liquidity at October 2, 2010 consisted primarily of $178.7 million in cash, cash equivalents and short-term investments, net of outstanding borrowings under our line of credit. We have a line of credit agreement with a brokerage firm. Under the terms of this agreement, we may borrow funds at a cost equal to the current Federal funds open rate plus 125 basis points (approximately 1.45% as of October 2, 2010). Certain of our cash, cash equivalents and marketable securities secure borrowings outstanding under this facility, but we are not restricted in the use of those assets. Funds are advanced to us under this facility in accordance with pre-determined advance rates based on the cash and securities held by us in this brokerage account. This agreement has no set expiration date and there are no loan covenants other than a collateral requirement. As of October 2, 2010, $6.0 million was outstanding under this facility, with a related collateral requirement of approximately $8.0 million of our cash, cash equivalents and short-term investments.

The development and manufacture of new lithography and laser-based systems and system enhancements is highly capital-intensive. In order to be competitive, we believe we must continue to make significant expenditures for capital equipment; sales, service, training and support capabilities; systems, procedures and controls; and expansion of operations and research and development, among many other items. We expect that cash generated from operations and our cash, cash equivalents and short-term investments will be sufficient to meet our cash requirements for at least the next twelve months. However, in the near-term, we may continue to utilize existing and future lines of credit, and other sources of financing, in order to maintain our present levels of cash, cash equivalents and investments. Beyond the next twelve months, we may require additional equity or debt financing to address our working capital or capital equipment needs. In addition, we may seek to raise equity or debt capital at any time that we deem market conditions to be favorable. Additional financing, if needed, may not be available on reasonable terms, or at all.

We may in the future pursue acquisitions of complementary product lines, technologies or businesses. Future acquisitions may result in potentially dilutive issuances of equity securities, the incurrence of debt and contingent liabilities and amortization expenses and impairment charges related to goodwill and other intangible assets, which could materially adversely affect our financial condition and results of operations. In addition, acquisitions involve numerous risks, including difficulties in the assimilation of the operations, technologies, personnel and products of the acquired companies; the diversion of management’s attention from other business concerns; risks of entering markets in which we have limited or no direct experience; and the potential loss of key employees of the acquired company. In the event we acquire product lines,

technologies or businesses which do not complement our business, or which otherwise do not enhance our sales or operating results, we may incur substantial write-offs and higher recurring operating costs, which could have a material adverse effect on our business, financial condition and results of operations. In the event that any such acquisition does occur, there can be no assurance as to the effect thereof on our business or operating results.

Foreign Currency

As part of our overall strategy to manage the level of exposure to the risk of foreign currency exchange rate fluctuations, we attempt to hedge most of our Japanese yen denominated foreign currency exposures. We use foreign currency forward contracts to hedge the risk that outstanding Japanese yen denominated receipts from customers, for actual or forecasted sales of our products after receipt of customer orders, may be adversely affected by changes in foreign currency exchange rates. We use foreign currency forward exchange contracts and natural hedges to offset substantial portions of the potential gains or losses associated with our Japanese yen denominated assets and liabilities due to exchange rate fluctuations. We enter into foreign currency forward contracts that generally have maturities of nine months or less.

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations is based upon our unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an on-going basis, we evaluate our critical accounting policies and estimates. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Our critical accounting policies and estimates are discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2009.

Information Available on Company Website

Our website is located at www.ultratech.com. We make available, free of charge through our website, our annual reports on
Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K (and amendments to those reports), as soon as reasonably practicable after such reports are filed electronically with the SEC. We have adopted a Code of Ethics for our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. We have posted this Code of Ethics on our website. Any future amendments to or waivers of this Code of Ethics will also be posted on our website.

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Reference is made to Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on
Form 10-K for the year ended December 31, 2009 and to the subheading “Derivative Instruments and Hedging” under the heading “Notes to Consolidated Financial Statements” in Item 8, “Financial Statements and Supplementary Data” of our Annual Report on Form 10-K for the year ended December 31, 2009.

Interest Rate Risk

Our exposure to market risk due to potential changes in interest rates relates primarily to our investment portfolio, which consisted primarily of fixed interest rate instruments as of October 2, 2010. We maintain an investment policy designed to ensure the safety and preservation of our invested funds by limiting market risk and the risk of default.

Certain of our cash, cash equivalents and short and long-term investments serve as collateral for a line of credit we maintain with a brokerage firm. The line of credit is used for liquidity purposes, mitigating the need to liquidate investments in order to meet our current operating cash requirements.

Credit Risk

We mitigate credit default risk by attempting to invest in high credit quality securities and by positioning our portfolio to respond appropriately to a significant reduction in a credit rating of any investment issuer or guarantor. Our portfolio includes only marketable securities with active secondary or resale markets to ensure portfolio liquidity and is diversified in accordance with our investment policy. To date, we have not experienced any liquidity problems with our portfolio.

As of October 2, 2010, we did not have any investments in mortgage backed or auction rate securities or any security investments in the financial service sector. However, we intend to closely monitor developments in the credit markets and make appropriate changes to our investment policy as we deem necessary or advisable. Based on our ability to liquidate our investment portfolio and our expected operating cash flows, we do not anticipate any liquidity constraints as a result of the current credit environment.

Foreign Currency Risk Management

The majority of our revenue, expense and capital purchasing activities are transacted in U.S. dollars. However, we do enter into these transactions in other currencies, primarily Japanese yen. To protect against reductions in value and the volatility of future cash flows caused by changes in currency exchange rates, we have established cash flow and balance sheet hedging programs.

We use foreign currency forward contracts to hedge the risk that outstanding Japanese yen denominated receipts from customers for actual or forecasted sales of equipment may be adversely affected by changes in foreign currency exchange rates. Our hedging programs reduce, but do not always entirely eliminate, the impact of currency movements. See “Derivative Instruments and Hedging” in Note 7 under the heading “Notes to Condensed Consolidated Financial Statements” of Part I, Item 1, “Financial Statements” herein for further disclosures.

Item 4.

Controls and Procedures

We conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as of the end of the period covered by this report (the “Evaluation Date”). Based upon the evaluation, our principal executive officer and principal financial officer concluded that, as of the Evaluation Date, our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure, and is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms.

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Management is further required to apply judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the three month period ended October 2, 2010 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1.

Legal Proceedings

On July 11, 2003, we filed a lawsuit against a Southern California company asserting infringement of certain claims related to U.S. patent No. 5,621,813 in the U.S. District Court in and for the Northern District of California. On May 17, 2005, the court found the subject patent to be invalid. We appealed this decision. The defendant subsequently brought a motion for reimbursement of its attorneys’ fees and costs in a total asserted amount of approximately $2 million. We opposed this motion, and on October 12, 2005, the District Court denied the defendant’s request for attorneys’ fees in its entirety. The defendant appealed that decision. On November 3, 2005, the defendant filed a notice of appeal with respect to the court’s ruling on its motion for attorneys’ fees. In March 2006, the Federal Circuit court upheld the district court’s ruling that the subject patent is invalid. On August 8, 2006, the Federal Circuit court upheld the District Court’s denial of attorneys’ fees. Neither side appealed the rulings by the Federal Circuit.

In May 2006, the same company filed a state court lawsuit against us for malicious prosecution and abuse of process claiming that attorney’s fees, costs and other damages were due based on the outcome of the federal patent litigation suit described above. We do not believe this action has merit, particularly given the denial by the federal court of that company’s request to be awarded attorneys’ fees payable by us in the patent litigation and the subsequent federal appellate court’s affirmation of the order denying any such award. We filed a motion to have the state court complaint dismissed under California’s anti-strategic lawsuit against public participation, or anti-SLAPP, and demurrer statutes. The anti-SLAPP statute is aimed at striking lawsuits that are brought in order to quash an individual’s constitutional rights to free speech or seeking redress of grievances (i.e., filing suit). The state court granted the anti-SLAPP motion as to the abuse of process claim, but denied it as to the malicious prosecution claim. Our subsequent appeals to the appellate court and California Supreme Court were unsuccessful, and the matter has returned to Riverside County Superior Court. We moved for summary judgment on the matter based on federal preemption, but the Superior Court denied the motion. A subsequent writ of mandamus filed by us was also not successful. Trial in the matter is now set for January 31, 2011.

Item 1A.

Risk Factors

In addition to risks described in the foregoing discussions, the following risks, among others, apply to our business and us:

The continuing uncertainty from the recent global financial and economic crisis could result in the cancellation, deferral or rescheduling of orders by our customers as well as changes in projection of new business.

Orders in backlog are subject to cancellation, deferral or rescheduling by a customer with limited or no penalties. Sales of our systems depend, in significant part, upon the decision of a prospective customer to increase manufacturing capacity or to restructure current manufacturing facilities, either of which typically involves a significant commitment of capital. Further, the purchase of our products involves a significant commitment of capital on the part of our customers. If the markets for our customers’ products experience a period of declining demand or if our customers’ ability to raise capital is limited, they may choose to cancel, delay or reschedule purchases of our products. The recent global financial and economic crisis and the continuing uncertainty created thereby could result in such a decline in demand or limited ability to raise capital, or could otherwise affect our customers’ markets, financial condition or willingness to incur expenses. As a result, we could experience the cancellation, delay or rescheduling of orders in our current backlog or of orders we currently expect to receive. Any such decision by our customers or potential customers would adversely affect our net sales and results of operations.

Our sales cycle is typically lengthy and involves a significant commitment of capital by our customers, which has subjected us, and is likely to continue to subject us, to delays in customer acceptances of our products and other risks, any of which could adversely impact our results of operations by, among other things, delaying recognition of revenue with respect to those orders and resulting in increased installation, qualification and similar costs.

Sales of our systems depend, in significant part, upon the decision of a prospective customer to increase manufacturing capacity, replace older equipment or to restructure current manufacturing facilities, any of which typically involves a significant commitment of capital. Many of our customers in the past have cancelled or postponed the development of new manufacturing facilities and have substantially reduced their capital equipment budgets. In view of the significant investment involved in a system purchase, we have experienced and may continue to experience delays following initial qualification of our systems as a result of delays in a customer’s approval process. Additionally, we are presently receiving orders for systems that have lengthy delivery schedules, which may be due to longer production lead times or a result of customers’ capacity scheduling requirements. For these and other reasons, our systems typically have a lengthy sales cycle during which we may expend substantial funds and management effort in securing a sale. Lengthy sales cycles subject us to a number of significant risks, including inventory obsolescence and fluctuations in operating results, over which we have little or no control. In order to maintain or exceed our present level of net sales, we are dependent upon obtaining orders for systems that will ship and be accepted in the current period. We may not be able to obtain those orders. Other important factors that could cause demand for our products to fluctuate include:

•

competitive pressures, including pricing pressures, from companies that have competing products;

•

changes in customer product needs; and

•

strategic actions taken by our competitors.

The semiconductor industry historically has been highly cyclical and has experienced periods of oversupply, which have in turn affected the market for semiconductor equipment such as ours and which can adversely affect our results of operations during such periods.

Our business depends in significant part upon capital expenditures by manufacturers of semiconductors, advanced packaging semiconductors and nanotechnology components which in turn depend upon the current and anticipated market demand for such devices and products utilizing such devices. The semiconductor industry historically has been highly cyclical and has experienced recurring periods of oversupply. This has, from time to time, resulted in significantly reduced demand for capital equipment including the systems manufactured and marketed by us. We believe that markets for new generations of semiconductors and semiconductor packaging will also be subject to similar fluctuations. Our business and operating results would be materially adversely affected by downturns or slowdowns in the semiconductor packaging market or by loss of market share. Accordingly, we may not be able to achieve or maintain our current or prior level of sales. We attempt to mitigate the risk of cyclicality by participating in multiple markets including semiconductor, semiconductor packaging, and nanotechnology sectors, as well as diversifying into new markets such as laser-based annealing for implant activation and other applications. Despite such efforts, when one or more of such markets experiences a downturn or a situation of excess capacity, our net sales and operating results are materially adversely affected.

We currently spend, and expect to continue to spend, significant resources to develop, introduce and commercialize our laser processing systems and lithography products, and we may not be successful in achieving or increasing sales of these products.

Currently, we are devoting significant resources to the development, introduction and commercialization of our laser products as well as our lithography wafer steppers. We intend to continue to develop these products and technologies during 2010 and 2011, and will continue to incur significant operating expenses in the areas of research, development and engineering, manufacturing and general and administrative costs in order to develop, produce and support these new products. Additionally, gross profit margins and inventory levels may be further adversely impacted in the future by costs associated with the initial production of our laser processing systems and by future generations of our 1X lithography systems. Introduction of new products generally involves higher installation costs and product performance uncertainties that could delay customer acceptance of our systems, resulting in a delay in recognizing revenue associated with those systems and a reduction in gross margins. These costs include, but are not limited to, additional manufacturing overhead, additional inventory write-downs, costs of demonstration systems and facilities and costs associated with the establishment of additional after-sales support organizations. Additionally, operating expenses may increase, relative to sales, as a result of adding additional marketing and administrative personnel, among other costs, to support our new products. If we are unable to achieve significantly increased net sales or if our sales fall below expectations, our operating results could be materially adversely affected.

Our ability to commercialize our laser processing technologies depends on our ability to demonstrate a manufacturing-worthy tool. We do not presently have in-house capability to fabricate devices. As a result, we must rely on partnering with semiconductor companies to develop the anneal process. The development of new process technologies is largely dependent upon our ability to interest potential customers in working on joint process development. Our ability to deliver timely solutions is also limited by wafer turnaround at the potential customer’s fabrication facility.

We operate in a highly competitive industry in which customers are required to invest substantial resources in each product, which makes it difficult to achieve significant sales to a particular customer once another vendor’s equipment has been purchased by that customer.

The capital equipment industry in which we operate is intensely competitive. A substantial investment is required to install and integrate capital equipment into a semiconductor, semiconductor packaging or nanotechnology device production line. We believe that once a device manufacturer or packaging subcontractor has selected a particular supplier’s capital equipment, the manufacturer generally relies upon that equipment for the specific production line application and, to the extent possible, subsequent generations of similar products. Accordingly, it is difficult to achieve significant sales to a particular customer once another supplier’s capital equipment has been selected.

We experience competition in advanced packaging from various proximity aligner companies such as Suss Microtec AG and used projection systems. In addition, some device manufacturers may consider using reduction steppers for advanced packaging processes. In nanotechnology, we experience competition from proximity aligner companies, such as Suss Microtec, as well as other stepper manufacturers who have developed or are developing tools specifically designed for nanotechnology applications. We expect our competitors in the lithography arena to continue to improve the performance of their current products and to introduce new products with improved price and performance characteristics. This could cause a decline in sales or loss of market acceptance of our steppers in our served markets, and thereby materially adversely affect our business, financial condition and results of operations. Enhancements to, or future generations of, competing products may be developed that offer superior cost of ownership and technical performance features.

With respect to our laser annealing technologies, marketed under the LSA100A product name, our primary competition comes from companies such as Dainippon Screen Manufacturing Co., Ltd., Applied Materials, Inc. and Mattson Technology, Inc. Many of these companies offer products utilizing rapid thermal processing (“RTP”) which is the current prevailing manufacturing technology. RTP does not prevent semiconductor device manufacturers from scaling the lateral dimensions of their transistors to obtain improved performance, but diffusion resulting from the time scales associated with RTP limits the vertical dimension of the junctions. Faster annealing times result in shallower and more abrupt junctions and faster transistors. We believe that RTP manufacturers recognize the need to reduce thermal cycle times and are working toward this goal. In July 2000, we licensed certain rights to our then existing laser processing technology, with reservations, to a competing manufacturer of semiconductor equipment. We presently anticipate that this company and others intend to offer laser annealing tools to the semiconductor industry that will compete with our offerings.

Another potential advanced annealing solution utilizes flash lamp annealing technology, or FLA. Several companies have published papers on annealing tools that incorporate flash lamp technology in order to reduce annealing times and increase anneal temperatures. Developers of FLA technology claim to have overcome annealing difficulties at the 65nm node. This technique, which employs flash lamps, has shown improvements over RTP in junction depth and sheet resistance, but we believe FLA suffers from pattern-related non-uniformities and could require additional, costly processes to equalize the reflectivity of different areas within the chip or wafer. Our proprietary laser processing solution has been specifically developed to provide junction annealing on near-instantaneous time-scales, while achieving high activation levels. Laser spike annealing, our first implementation of laser processing, activates dopants in the microsecond-to-millisecond time frame without melting. Our research indicates that, at temperatures just below the melting point of silicon, time durations in the microsecond to millisecond range, are required to achieve full activation, and minimal dopant diffusion.

Additionally, competition to our laser processing products may come from other laser annealing tools, including those presently being used by the flat panel display industry to re-crystallize silicon. Manufacturers of these tools may try to extend the use of their technologies to semiconductor device applications.

We believe that in order to be competitive, we will need to continue to invest significant financial resources in new product development, new features and enhancements to existing products, the introduction of new stepper systems in our served markets on a timely basis, and maintaining customer service and support centers worldwide. In marketing our products, we may also face competition from vendors employing other technologies. In addition, increased competitive pressure has led to intensified price-based competition in certain of our markets, resulting in lower prices and margins. Should these competitive trends continue, our business, financial condition, and operating results may be materially adversely affected.

We sell our products primarily to a limited number of customers and to customers in a limited number of industries, which subjects us to increased risks related to the business performance of our customers, and therefore their need for our products, and the business cycles of the markets into which we sell.

Historically, we have sold a substantial portion of our systems to a limited number of customers. In the three month and nine month periods ended October 2, 2010, our top five customers accounted for 74.1% and 66.8%, respectively, of our system sales compared to 100% and 76.4%, respectively, in the comparable periods of 2009. We expect that sales to a relatively few customers will continue to account for a high percentage of our net sales in the foreseeable future and believe that our financial results depend in significant part upon the success of these major customers and our ability to meet their future capital equipment needs. Although the composition of the group comprising our largest customers may vary from period to period, the loss of a significant customer or any reduction in orders by a significant customer, including reductions due to market, economic or competitive conditions in the semiconductor, semiconductor packaging or nanotechnology industries or in the industries that manufacture products utilizing integrated circuits, thin film heads or other nanotechnology components, would likely have a material adverse effect on our business, financial condition and results of operations. Our ability to maintain or increase our sales in the future depends, in part, on our ability to obtain orders from new customers as well as the financial condition and success of our existing customers, the semiconductor and nanotechnology industries and the economy in general.

In addition to the business risks associated with dependence on a few major customers, these significant customer concentrations have in the past resulted in significant concentrations of accounts receivable. These significant and concentrated receivables expose us to additional risks, including the risk of default by one or more customers representing a significant portion of our total receivables. If we were required to take additional accounts receivable reserves, our business, financial condition and results of operations would be materially adversely affected.

On a market application basis, sales to the semiconductor industry, primarily for advanced packaging applications and laser thermal processing applications, accounted for 100% of our system sales for the three months ended October 2, 2010, and for the comparable period in 2009. The Company had no sales to nanotechnology manufacturers for the three months ended

October 2, 2010 and three months ended October 3, 2009, respectively. Our future operating results and financial condition would be materially adversely impacted by a downturn in any of these industries, or by loss of market share in any of these industries. A growing portion of our backlog of system orders is comprised of laser spike annealing tools. As our laser spike annealing tools are used for the continuation of reduced device geometries and customers seldom provide us with their future technical requirements, these tools may not meet all customers’ requirements upon initial delivery and installation at the customer’s facility. As a result, acceptance of the tool by the customer could be delayed while we perform testing and attempt to meet their requirements, or the order could be cancelled if we are unable to meet those requirements. Should significant demand for these systems not materialize, due to technical, production, market, or other factors, our business, financial position and results of operations would be materially adversely impacted.

We rely on a limited number of outside suppliers and subcontractors to manufacture certain components and subassemblies, and on single or a limited group of outside suppliers for certain materials for our products, which could result in a potential inability to obtain an adequate supply of required components due to the suppliers’ failure or inability to provide such components in a timely manner, or at all, and reduced control over pricing and timely delivery of components and materials, any of which could adversely affect our results of operations.

Our manufacturing activities consist of assembling and testing components and subassemblies, which are then integrated into finished systems. We rely on a limited number of outside suppliers and subcontractors to manufacture certain components and subassemblies. We order one of the most critical components of our technology, the glass for our 1X lenses, from external suppliers. We design the 1X lenses and provide the lens specifications and the glass to other suppliers, who then grind and polish the lens elements. We then assemble and test the optical 1X lenses.

We procure some of our other critical systems’ components, subassemblies and services from single outside suppliers or a limited group of outside suppliers in order to ensure overall quality and timeliness of delivery. Many of these components and subassemblies have significant production lead times. To date, we have been able to obtain adequate services and supplies of components and subassemblies for our systems in a timely manner. However, disruption or termination of certain of these sources could have a significant adverse impact on our ability to manufacture our systems. This, in turn, would have a material adverse effect on our business, financial condition and results of operations. Our reliance on a sole supplier or a limited group of suppliers and our reliance on subcontractors involve several risks, including a potential inability to obtain an adequate supply of required components due to the suppliers’ failure or inability to provide such components in a timely manner, or at all, and reduced control over pricing and timely delivery of components. Although the timeliness, yield and quality of deliveries to date from our subcontractors have been acceptable, manufacture of certain of these components and subassemblies is an extremely complex process, and long lead-times are required. Any inability to obtain adequate deliveries or any other circumstance that would require us to seek alternative sources of supply or to manufacture such components internally could delay our ability to ship our products, which could damage relationships with current and prospective customers and have a material adverse effect on our business, financial condition and results of operations.

Our industry is subject to rapid technological change and product innovation, which could result in our technologies and products being replaced by those of our competitors, which would adversely affect our business and results of operations.

The semiconductor and nanotechnology manufacturing industries are subject to rapid technological change, evolving industry standards and new product introductions and enhancements. Our ability to be competitive in these and other markets will depend, in part, upon our ability to develop new and enhanced systems and related applications, and to introduce these systems and related applications at competitive prices and on a timely and cost-effective basis to enable customers to integrate them into their operations either prior to or as they begin volume product manufacturing. We will also be required to enhance the performance of our existing systems and related applications. Our success in developing new and enhanced systems and related applications depends upon a variety of factors, including product selection, timely and efficient completion of product design, timely and efficient implementation of manufacturing and assembly processes, product performance in the field and effective sales and marketing. Because new product development commitments must be made well in advance of sales, new product decisions must anticipate both future customer requirements and the technology that will be available to meet those requirements. We may not be successful in selecting, developing, manufacturing or marketing new products and related applications or enhancing our existing products and related applications. Any such failure would materially adversely affect our business, financial condition and results of operations. Further, we may make substantial investments in new products before we know whether they are technically feasible or commercially viable, and as a result may incur significant product development expenses that do not result in new products or revenues.

Because of the large number of components in our systems, significant delays can occur between a system’s introduction and our commencement of volume production of such systems. We have experienced delays from time to time in the introduction of, and technical and manufacturing difficulties with, certain of our systems and enhancements and related application tools features and options, and may experience delays and technical and manufacturing difficulties in future introductions or volume production of new systems or enhancements and related application tools features and options.

We may encounter additional technical, manufacturing or other difficulties that could further delay future introductions or volume production of systems or enhancements. Our inability to complete the development or meet the technical specifications of any of our systems or enhancements and related applications, or our inability to manufacture and ship these systems or enhancements and related tools in volume and in time to meet the requirements for manufacturing the future generation of semiconductor or nanotechnology devices would materially adversely affect our business, financial condition and results of operations. In addition, we may incur substantial unanticipated costs to ensure the functionality and reliability of our products early in the products’ life cycles. If new products have reliability or quality problems, reduced orders or higher manufacturing costs, delays in customer acceptance, revenue recognition and collecting accounts receivable and additional service and warranty expenses may result. Any of such events may materially adversely affect our business, financial condition and results of operations.

We may not be successful in protecting our intellectual property rights or we could be found to have infringed the intellectual property rights of others, either of which could weaken our competitive position and adversely affect our results of operations.

Although we attempt to protect our intellectual property rights through patents, copyrights, trade secrets and other measures, we believe that our success will depend more upon the innovation, technological expertise and marketing abilities of our employees. Nevertheless, we have a policy of seeking patents when appropriate on inventions resulting from our ongoing research and development and manufacturing activities. We own 167 U.S. and foreign patents, which expire on dates ranging from October 2010 to March 2027 and have 57 U.S. and foreign patent applications pending. In addition, we have various registered trademarks and copyright registrations covering mainly applications used in the operation of our systems. We also rely upon trade secret protection for our confidential and proprietary information. We may not be able to protect our technology adequately and competitors may be able to develop similar technology independently. Our pending patent applications may not be issued or U.S. or foreign intellectual property laws may not protect our intellectual property rights. In addition, litigation may be necessary to enforce our patents, copyrights or other intellectual property rights, to protect our trade secrets, to determine the validity and scope of the proprietary rights of others or to defend against claims of infringement. Such litigation has resulted in, and in the future could result in, substantial costs and diversion of resources and could have a material adverse effect on our business, financial condition and results of operations, regardless of the outcome of the litigation. Patents issued to us may be challenged, invalidated or circumvented and the rights granted thereunder may not provide competitive advantages to us. Furthermore, others may independently develop similar technology or products, or, if patents are issued to us, design around the patents issued to us. Invalidation of our patents related to those technologies, or the expiration of patents covering our key technologies, could allow our competitors to more effectively compete against us, which could result in less revenue for us.

In May 2006, the same company filed a state court lawsuit against us for malicious prosecution and abuse of process claiming that attorney’s fees, costs and other damages were due based on the outcome of the federal patent litigation suit described above. We do not believe this action has merit, particularly given the denial by the federal court of that company’s request to be awarded attorneys’ fees payable by us in the patent litigation and the subsequent federal appellate court’s affirmation of the order denying any such award. We filed a motion to have the state court complaint dismissed under California’s anti-strategic lawsuit against public participation (“anti-SLAPP”) and demurrer statutes. The anti-SLAPP statute is aimed at striking lawsuits that are brought in order to quash an individual’s constitutional rights to free speech or seeking redress of grievances (i.e. filing suit). The state court granted the anti-SLAPP motion as to the abuse of process claim, but denied it as to the malicious prosecution claim. Our subsequent appeals to the appellate court and California Supreme Court were unsuccessful, and the matter was returned to Riverside County Superior Court. We moved for summary judgment on the matter based on federal preemption, but the Superior Court denied the motion. A subsequent writ of mandamus filed by us was also not successful. Trial in the matter is now set for January 31, 2011.

We believe that the outcome of these matters will not be material to our business, financial condition or results of operations.

We have from time to time been notified of claims that we may be infringing intellectual property rights possessed by third parties. We believe that the outcome of these matters will not be material to our business, results of operations or financial condition.

Infringement claims by third parties or claims for indemnification resulting from infringement claims may be asserted in the future and such assertions could materially adversely affect our business, financial condition and results of operations, regardless of the outcome of any litigation. With respect to any such future claims, we may seek to obtain a license under the third party’s intellectual property rights. However, a license may not be available on reasonable terms or at all. We could decide, in the alternative, to resort to litigation to challenge such claims. Such challenges could be expensive and time consuming and could materially adversely affect our business, financial condition and results of operations, regardless of the outcome of any litigation.

A substantial portion of our sales are outside of the United States, which subjects us to risks related to customer service, installation, foreign economic and political stability, uncertain regulatory and tax rules, and foreign exchange rate fluctuations, all of which make it more difficult to operate our business.

International sales accounted for approximately 78.5% and 86.8% of total net sales for the three month and nine month periods ended October 2, 2010, respectively, compared to 86.8% and 65.3%, respectively, in the comparable periods of 2009. We anticipate that international sales will continue to account for a significant portion of total net sales. As a result, a significant portion of our net sales will continue to be subject to certain risks, including unexpected changes in regulatory requirements; difficulty in satisfying existing regulatory requirements; exchange rate fluctuations; tariffs and other barriers; political and economic instability; difficulties in accounts receivable collections; reduced protection of intellectual property; natural disasters; difficulties in staffing and managing foreign subsidiary and branch operations; and potentially adverse tax consequences.

Although we generally transact our international sales in U.S. dollars, international sales expose us to a number of additional risk factors, including fluctuations in the value of local currencies relative to the U.S. dollar, which, in turn, impact the relative cost of ownership of our products and may further impact the purchasing ability of our international customers. We have direct sales operations in Japan and orders are often denominated in Japanese yen. This may subject us to a higher degree of risk from currency fluctuations. We attempt to mitigate this exposure through foreign currency hedging. We are also subject to the risks associated with the imposition of legislation and regulations relating to the import or export of semiconductors and nanotechnology products. We cannot predict whether the United States or any other country will implement changes to quotas, duties, taxes or other charges or restrictions upon the importation or exportation of our products. These factors, or the adoption of restrictive policies, may have a material adverse effect on our business, financial condition and results of operations.

We continue to expand our manufacturing operations in Singapore, which will continue to expose us to risks inherent in doing business outside the United States, any of which risks could harm our business, financial condition and operating results.

Foreign operations subject us to risks related to the political, economic, legal and other conditions of foreign jurisdictions. These risks include risks related to:

•

foreign exchange rate fluctuations;

•

the need to comply with foreign government laws and regulations, including the imposition of regulatory requirements, tariffs, and import and export restrictions;

•

general geopolitical risks such as political and economic instability and changes in diplomatic and trade relationships;

•

potentially less protection of intellectual property under the laws of foreign jurisdictions; and

•

public safety or health concerns or natural disasters in foreign countries.

These risks could, among other things, result in product shipment delays, increased costs, unexpected shutdowns or other business disruptions, or loss of benefits expected to be achieved by conducting operations in affected jurisdictions. Any of the above risks, should they occur, could have a material adverse effect on our business, financial condition and results of operations.

Our investment portfolio may become impaired by further deterioration of the capital markets.

Our cash equivalent and short-term investment portfolio as of October 2, 2010 consisted of securities and obligations of U.S. government agencies, money market funds, commercial paper and corporate debt securities. We follow an established investment policy and set of guidelines to monitor, manage and limit our exposure to interest rate and credit risk. The policy sets forth credit quality standards and limits our exposure to any one issuer, as well as our maximum exposure to various asset classes.

As a result of current financial market conditions, investments in some financial instruments, such as structured investment vehicles, sub-prime mortgage-backed securities and collateralized debt obligations, may lose some or all of their value due to liquidity and credit concerns. As of October 2, 2010, we had no holdings in these categories of investments and no impairment charge associated with our short-term investment portfolio. Although we believe our current investment portfolio has little risk of impairment, we cannot predict future market conditions or market liquidity and our investment portfolio could become impaired.

We are dependent on our key personnel, especially Mr. Zafiropoulo, our Chief Executive Officer, and our business and results of operations would be adversely affected if we were to lose our key employees.

Our future operating results depend, in significant part, upon the continued contributions of key personnel, many of whom would be difficult to replace. We have entered into employment agreements only with our Chief Executive Officer and Chief Financial Officer, and our employees are employed “at will.” The agreements with our Chief Executive Officer and Chief Financial Officer contain vesting acceleration and severance payment provisions that could result in significant costs or charges to us should the employee be terminated without cause, die or have a disability. We do not maintain any life insurance on any of our key employees. The loss of key personnel could have a material adverse effect on our business, financial condition and results of operations. In addition, our future operating results depend in significant part upon our ability to attract and retain other qualified management, manufacturing, technical, sales and support personnel for our operations. There are only a limited number of persons with the requisite skills to serve in these positions and it may become increasingly difficult for us to hire such personnel over time. At times, competition for such personnel has been intense, particularly in the San Francisco Bay Area where we maintain our headquarters and principal operations, and we may not be successful in attracting or retaining such personnel. The failure to attract or retain such persons would materially adversely affect our business, financial condition and results of operations.

Changes in financial accounting standards or policies in the past have affected, and in the future may, affect, our reported results of operations.

We prepare our financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”). These principles are subject to interpretation by the Financial Accounting Standards Board (“FASB”), the American Institute of Certified Public Accountants (“AICPA”), the Securities and Exchange Commission (“SEC”) and various bodies formed to interpret and create appropriate accounting policies. A change in those policies can have a significant effect on our reported results and may affect our reporting of transactions which are completed before a change is announced.

Accounting policies affecting many other aspects of our business, including rules relating to revenue recognition, off-balance sheet transactions, employee stock options and other equity awards, restructurings, asset disposals and asset retirement obligations, derivative and other financial instruments have recently been revised or are under review. Changes to those rules or the questioning of how we interpret or implement those rules may have a material adverse effect on our reported financial results or on the way we conduct business. In addition, our preparation of financial statements in accordance with U.S. GAAP requires that we make estimates and assumptions that affect the recorded amounts of assets and liabilities, disclosure of those assets and liabilities at the date of the financial statements and the recorded amounts of expenses during the reporting period. A change in the facts and circumstances surrounding those estimates could result in a change to our estimates and could impact our future operating results.

Our equity incentive plans, certain provisions of our Certificate of Incorporation and Bylaws, and Delaware law may discourage third parties from pursuing a change of control transaction with us.

Certain provisions of our Certificate of Incorporation, equity incentive plans, licensing agreements, Bylaws and Delaware law may discourage certain transactions involving a change in control of our company. In addition to the foregoing, the shareholdings of our officers, directors and persons or entities that may be deemed affiliates and the ability of the Board of Directors to issue “blank check” preferred stock without further stockholder approval could have the effect of delaying, deferring or preventing us from experiencing a change in control and may adversely affect the voting and other rights of holders of our Common Stock.

We use hazardous substances in the operation of our business, and any failure on our part to comply with applicable regulations or to appropriately control the use, disposal or storage of such substances could subject us to significant liabilities.

We are subject to a variety of governmental regulations relating to environment protection and workplace safety, including the use, storage, discharge, handling, emission, generation, manufacture and disposal of toxic or other hazardous substances. The failure to comply with current or future regulations could result in substantial fines being imposed on us, suspension of production, alteration of the manufacturing process or cessation of operations. Such regulations could require us to acquire expensive remediation equipment or to incur substantial expenses to comply with environmental regulations. Any failure by us to comply with these regulations, including any failure to control the use, disposal or storage of, or adequately restrict the discharge of, hazardous or toxic substances, could subject us to significant liabilities.

Our results of operations and business could be adversely affected by public health issues, wars and other military action, as well as terrorist attacks and threats and government responses thereto, especially if any such actions were directed at us or our facilities or customers.

Public health issues, terrorist attacks in the United States and elsewhere, government responses thereto, and military actions in Iraq, Afghanistan and elsewhere, may disrupt our operations or those of our customers and suppliers and may affect the availability of materials needed to manufacture our products or the means to transport those materials to manufacturing facilities and finished products to customers. Significant public health issues could cause damage or disruption to international commerce by creating economic and political uncertainties that may have a significant negative impact on the global economy, us and our customers or suppliers. Should such increase or other public health issues arise, we could be negatively impacted by the need for more stringent employee travel restrictions, additional limitations in the availability of freight services, governmental actions limiting the movement of products between various regions and disruptions in the operations of our customers or suppliers. Any public health issues, any terrorist attacks, or the ongoing war on terrorism or other wars could increase volatility in the United States and world financial markets which may depress the price of our Common Stock and may limit the capital resources available to us or our customers or suppliers, which could result in decreased orders from customers, less favorable financing terms from suppliers, and scarcity or increased costs of materials and components of our products. Additionally, if any of these events were to directly affect or be specifically directed at us, it could significantly disrupt our ability to conduct our business. Any of these occurrences could have a significant impact on our operating results, revenues and costs and may result in increased volatility of the market price of our Common Stock.

Our stock price has experienced significant volatility in the past and we expect this to continue in the future as a result of many factors, some of which could be unrelated to our operating performance, and such volatility can have a major impact on the number of shares subject to outstanding stock options and restricted stock units that are included in calculating our earnings per share.

We believe that factors such as announcements of developments related to our business, fluctuations in our operating results, a shortfall in revenue or earnings, changes in analysts’ expectations, general conditions in the semiconductor and nanotechnology industries or the worldwide or regional economies, sales of our securities into the marketplace, an outbreak or escalation of hostilities, announcements of technological innovations or new products or enhancements by us or our competitors, developments in patents or other intellectual property rights and developments in our relationships with our customers and suppliers could cause the price of our Common Stock to fluctuate, perhaps substantially. The market price of our Common Stock has fluctuated significantly in the past and we expect it to continue to experience significant fluctuations in the future, including fluctuations that may be unrelated to our performance.

As of October 2, 2010, we had outstanding options to purchase and restricted stock units for 4.3 million shares of our Common Stock outstanding. Among other determinants, the market price of our stock has a major bearing on the number of shares subject to outstanding stock options and restricted stock units that are included in the weighted-average shares used in determining our net income per share. During periods of extreme volatility, the impact of higher stock prices can have a materially dilutive effect on our net income per share. Additionally, shares subject to outstanding options and restricted stock units are excluded from the calculation of net income per share when we have a net loss or when the exercise price and the average unrecognized compensation cost of the stock option or restricted stock unit is greater than the average market price of our Common Stock, as the impact of the stock options or restricted stock units would be anti-dilutive.

If we acquire companies, products, or technologies, we may face risks associated with those acquisitions.

We may not realize the anticipated benefits of any acquisition or investment. We may in the future pursue additional acquisitions of complementary product lines, technologies or businesses. Future acquisitions may result in potentially dilutive issuances of equity securities, the incurrence of debt and contingent liabilities and amortization expenses and impairment charges related to goodwill and other intangible assets, which could materially adversely affect our financial condition and

results of operations. In addition, acquisitions involve numerous risks, including difficulties in the assimilation of the operations, technologies, personnel and products of the acquired companies; the diversion of management’s attention from other business concerns; risks of entering markets in which we have limited or no direct experience; and the potential loss of key employees of the acquired company. In the event we acquire product lines, technologies or businesses which do not complement our business, or which otherwise do not enhance our sales or operating results, we may incur substantial write-offs and higher recurring operating costs, which could have a material adverse effect on our business, financial condition and results of operations. In the event that any such acquisition does occur, there can be no assurance as to the effect thereof on our business or operating results.

Our long-term expenses reduction programs may result in an increase in short-term expenses.

As part of our continued effort to reduce company-wide expenses, we have recorded certain expenses related to work force reductions pursuant to the provisions of Accounting Standard Codification (“ASC”) Topic 420, Exit or Disposal Cost Obligations. Although we expect our cost cutting efforts to result in a decrease in expenses over the long-term, these accounting charges may result in an increase in our short-term expenses. We may from time to time undertake additional expense reduction programs or actions, any of which could result in current period charges and expenses that could have a material adverse effect on that period’s operating results.

If earthquakes or other catastrophic events occur, our business may be harmed.

We currently perform all of our manufacturing activities in cleanroom environments in San Jose, California, an area known for seismic activity. Performing manufacturing operations in California exposes us to a higher risk of natural disasters, including earthquakes. In addition, in the past California has experienced power shortages, which have interrupted our operations. Such shortages could occur in the future. An earthquake, other natural disaster, power shortage or other similar events could interrupt or otherwise limit our operations resulting in product shipment delays, increased costs and other problems, any of which could have a material adverse effect on our business, customer relationships and results of operations.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Reserved

Item 5.

Other Information

None.

Item 6.

Exhibits



3.1(a)		Amended and Restated Certificate of Incorporation of the Registrant, filed October 6, 1993.

3.1.1(a)		Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, filed May 17, 1995.

3.1.2(a)		Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, filed June 17, 1998.

3.1.3(a)		Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, filed June 20, 2003.

3.1.4(b)		Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, filed August 31, 2009.

3.2(c)		Amended and Restated Bylaws of the Registrant, as amended.

10.1(d)		1993 Stock Option/Stock Issuance Plan (amended and restated as of June 7, 2010).

31.1		Certification of Chief Executive Officer required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Chief Financial Officer required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*		Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

(a)	Previously filed with our Quarterly Report on Form 10-Q for the quarter ended June 28, 2003 (Commission File No. 0-22248) and incorporated herein by reference.

(b)	Previously filed with our Quarterly Report on Form 10-Q for quarter ended October 3, 2009 (Commission File No. 0-22248) and incorporated herein by reference.

(c)	Previously filed with our Current Report on Form 8-K filed on October 20, 2008 (Commission File No. 0-22248) and incorporated herein by reference.

(d)	Previously filed with our Current Report on Form 8-K filed on July 23, 2010 (Commission File No. 0-22248) and incorporated herein by reference.

Exhibit 32.1 is being furnished and shall not be deemed to be filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall such exhibit be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act, or the Exchange Act, except as otherwise stated in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

EXHIBIT INDEX



3.1(a)		Amended and Restated Certificate of Incorporation of the Registrant, filed October 6, 1993.

3.1.1(a)		Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, filed May 17, 1995.

3.1.2(a)		Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, filed June 17, 1998.

3.1.3(a)		Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, filed June 20, 2003.

3.1.4(b)		Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, filed August 31, 2009.

3.2(c)		Amended and Restated Bylaws of the Registrant, as amended.

10.1(d)		1993 Stock Option/Stock Issuance Plan (amended and restated as of June 7, 2010).

31.1		Certification of Chief Executive Officer required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Chief Financial Officer required pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*		Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

(a)	Previously filed with our Quarterly Report on Form 10-Q for the quarter ended June 28, 2003 (Commission File No. 0-22248) and incorporated herein by reference.

(b)	Previously filed with our Quarterly Report on Form 10-Q for the quarter ended October 3, 2009 (Commission File No. 0-22248) and incorporated herein by reference.

(c)	Previously filed with our Current Report on Form 8-K on October 20, 2008 (Commission File No. 0-22248) and incorporated herein by reference.

(d)	Previously filed with our Current Report on Form 8-K filed on July 23, 2010 (Commission File No. 0-22248) and incorporated herein by reference.

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if a smaller reporting company)

Smaller reporting company